<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cgd" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cgd</book-part-id>
      <title-group>
        <title>Chronic Granulomatous Disease</title>
        <alt-title alt-title-type="alt-title">Synonym: CGD</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Leiding</surname>
            <given-names>Jennifer W</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Pediatrics<break/>Division of Allergy and Immunology<break/>University of South Florida<break/>St Petersburg, Florida</aff>
          <email>jleiding@health.usf.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Holland</surname>
            <given-names>Steven M</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Laboratory of Clinical Infectious Diseases<break/>National Institute of Allergy and Infectious Diseases<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>sholland@niaid.nih.gov</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>9</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="updated">
          <day>11</day>
          <month>2</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="choroid" document-type="chapter">Choroideremia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="citrin" document-type="chapter">Citrin Deficiency</related-object>
      <abstract id="cgd.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder of phagocytes (neutrophils, monocytes, macrophages, and eosinophils) resulting from impaired killing of bacteria and fungi. CGD is characterized by severe recurrent bacterial and fungal infections and dysregulated inflammatory response resulting in granuloma formation and other inflammatory disorders such as colitis. Infections typically involve the lung (pneumonia), lymph nodes (lymphadenitis), liver (abscess), bone (osteomyelitis), and skin (abscesses or cellulitis); granulomas typically involve the genitourinary system (bladder) and gastrointestinal tract (often the pylorus initially, and later the esophagus, jejunum, ileum, cecum, rectum, and perirectal area). Some males with X-linked CGD have McLeod neuroacanthocytosis syndrome as the result of a contiguous gene deletion. CGD may present any time from infancy to late adulthood; however, the vast majority of affected individuals are diagnosed before age five years. Use of antimicrobial prophylaxis and therapy has greatly improved overall survival.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>CGD is diagnosed by tests that measure neutrophil superoxide production via the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex: the dihydrorhodamine (DHR) test has largely replaced the nitroblue tetrazolium (NBT) test, the oldest and most recognized diagnostic test for CGD. CGD is caused by pathogenic variants in one of five genes that encode the subunits of phagocyte NADPH oxidase: biallelic pathogenic variants in <italic toggle="yes">CYBA</italic>, <italic toggle="yes">NCF1</italic>, <italic toggle="yes">NCF2,</italic> and <italic toggle="yes">NCF4</italic> cause autosomal recessive CGD (AR-CGD); mutation of <italic toggle="yes">CYBB</italic> causes X-linked CGD.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> A definitive microbiologic diagnosis is essential to proper treatment of infections. Newer azole drugs (voriconazole, posaconazole, isovuconazole) have expanded therapeutic options for fungal infections. Long courses of antimicrobials are often needed for adequate treatment. Abscesses may require percutaneous drainage or excisional surgery. Simultaneous administration of antimicrobials and corticosteroids can help resolve the associated heightened inflammatory response, including colitis.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Allogeneic hematopoietic stem cell transplantation (HSCT) is the only known cure for CGD; however, indications for and timing of HSCT are yet to be resolved. Antibacterial and antifungal prophylaxis is the cornerstone of prevention; immunomodulatory therapy with interferon gamma (IFN-gamma) is part of the prophylactic regimen in many centers.</p>
          <p><italic toggle="yes">Surveillance:</italic> Regular follow-up visits can aid in early detection and treatment of asymptomatic or minimally symptomatic infections and non-infectious complications such as colitis, pulmonary granulomas, and pulmonary fibrosis.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> (1) Decayed organic matter (e.g., mulching, gardening, leaf raking, house demolition) as inhalation of fungal spores can result in fulminant pneumonitis; (2) bacille Calmette-Gu&#x000e9;rin (BCG) vaccination; (3) Persons with CGD and McLeod neuroacanthocytosis syndrome: blood transfusions that are Kell antigen positive.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Early diagnosis of relatives at risk allows for prompt initiation of antimicrobial prophylaxis and other treatment.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> The major concern during the pregnancy of a woman known to have CGD is use of prophylactic antimicrobials: trimethoprim, a folic acid antagonist, is discontinued during pregnancy because of the high risk for birth defects. Although sulfamethoxazole is not known to increase the risk of birth defects in humans, it is typically administered in conjunction with trimethoprim. Data regarding teratogenicity of itraconazole are limited.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>CGD associated with a pathogenic variant in <italic toggle="yes">CYBB</italic> is inherited in an X-linked manner. CGD associated with biallelic pathogenic variants in <italic toggle="yes">CYBA</italic>, <italic toggle="yes">NCF1</italic>, <italic toggle="yes">NCF2</italic>, or <italic toggle="yes">NCF4</italic> is inherited in an autosomal recessive manner.</p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">X-linked CGD.</italic> If the mother of an affected male is heterozygous for a <italic toggle="yes">CYBB</italic> pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be heterozygous and will usually not be affected with typical CGD but may have other manifestations including discoid lupus erythematosus and aphthous ulcers.</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">AR-CGD.</italic> At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
          </list>
          <p>Molecular genetic carrier testing and prenatal testing for pregnancies at increased risk is possible if the pathogenic variant(s) in a family are known. (Other carrier and prenatal testing options may be available if the pathogenic variant[s] in the family are not known.)</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cgd.Diagnosis">
        <title>Diagnosis</title>
        <sec id="cgd.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Chronic granulomatous disease (CGD) <bold>should be suspected</bold> in individuals (usually children) with the following clinical features and laboratory testing:</p>
          <sec id="cgd.Clinical_features">
            <title>Clinical features</title>
            <list list-type="bullet">
              <list-item>
                <p>Growth retardation in childhood</p>
              </list-item>
              <list-item>
                <p>Infections of lung (pneumonia), lymph nodes (lymphadenitis), liver (abscess), bone (osteomyelitis), and skin (abscesses or cellulitis), especially spontaneously occurring severe or recurrent bacterial infections. Microbiologic confirmation of the cause of infection helps confirm the likelihood of CGD, since the spectrum of infection in CGD is distinct and narrow (see <xref ref-type="table" rid="cgd.T.infections_in_cgd_common_pathogens">Table 2</xref>).</p>
              </list-item>
              <list-item>
                <p>Granuloma formation, especially genitourinary (bladder) and gastrointestinal (often pyloric initially, and later esophageal, jejunal, ileal, cecal, rectal, and perirectal)</p>
              </list-item>
              <list-item>
                <p>Colitis, manifesting as frequent stooling and fistulae or fissures. This may be the sole finding in some individuals.</p>
              </list-item>
              <list-item>
                <p>Abnormal wound healing caused by excessive granulation, which may cause the wound to dehisce and gape, leading to healing by secondary intention</p>
              </list-item>
            </list>
          </sec>
          <sec id="cgd.Laboratory_testing">
            <title>Laboratory testing</title>
            <p>Clinical tests that rely on direct measurement of neutrophil superoxide production via the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex to establish the diagnosis of CGD include the following:</p>
            <p><bold>Dihydrorhodamine (DHR) test</bold> uses flow cytometry to measure the oxidation of dihydrorhodamine 123 to rhodamine 123 in phorbol myrisate acetate (PMA)-stimulated neutrophils, a marker for cellular NADPH oxidase activity [<xref ref-type="bibr" rid="cgd.REF.vowells.1996.104">Vowells et al 1996</xref>]. In this test the generation of hydrogen peroxide oxidizes the dye, leading to the emission of fluorescence. Mean fluorescence intensity of the activated cells correlates directly with (and thus serves as a reliable surrogate for) superoxide production [<xref ref-type="bibr" rid="cgd.REF.kuhns.2010.2600">Kuhns et al 2010</xref>].</p>
            <p>The DHR test can distinguish the following forms of CGD:</p>
            <list list-type="bullet">
              <list-item>
                <p>Complete forms (i.e., those with absent to greatly diminished production of superoxide) commonly observed in males with X-linked CGD</p>
              </list-item>
              <list-item>
                <p>Hypomorphic (variant) forms of CGD characterized by reduced protein expression/function and residual superoxide production (observed in autosomal recessive CGD and protein-positive X-linked CGD)</p>
              </list-item>
              <list-item>
                <p>Mosaic forms (i.e., those with two discrete populations of phagocytes: some oxidase-positive and some oxidase-negative) commonly observed in female carriers of X-linked CGD</p>
                <p>Note: Although the pattern of oxidase-positive and oxidase-negative phagocytes can suggest X-linked inheritance of CGD or autosomal recessive inheritance of CGD, the results are not definitive in establishing the mode of inheritance.</p>
              </list-item>
            </list>
            <p>Although the DHR is superior to other tests for CGD, it is not always clinically available to ordering clinicians, and the nitroblue tetrazolium (NBT) test is ordered in its place.</p>
            <p><bold>Nitroblue tetrazolium (NBT) test</bold>, the oldest and most recognized diagnostic test for CGD, relies on light microscopy to provide a mostly qualitative determination of phagocyte NADPH oxidase activity. When stimulated in vitro, normal phagocytes produce superoxide that reduces yellow NBT to blue/black formazan, forming a precipitate in cells [<xref ref-type="bibr" rid="cgd.REF.baehner.1967.835">Baehner &#x00026; Nathan 1967</xref>]. The NBT test is typically performed on a microscope slide, which is read manually to distinguish reducing (blue-black) from non-reducing (unstained) cells:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Neutrophils in unaffected non-carriers.</bold> More than 95% of cells produce superoxide that reduces NBT to formazan.</p>
              </list-item>
              <list-item>
                <p><bold>Neutrophils in individuals with CGD.</bold> Production of superoxide is absent or greatly diminished.</p>
              </list-item>
              <list-item>
                <p><bold>Female carriers of X-linked CGD</bold> (who have two populations of leukocytes). Superoxide is typically produced in 20%-80% of cells [<xref ref-type="bibr" rid="cgd.REF.elloumi.2014.517">Elloumi &#x00026; Holland 2014</xref>] (range: 0.001%-97%).</p>
                <p>Note: Because the NBT test is semi-quantitative and evaluates only a limited number of cells, it may be falsely interpreted as normal in: (1) female carriers of X-linked CGD, especially those with skewed (non-random) X-chromosome inactivation (see <xref ref-type="sec" rid="cgd.Carriers_of_XLinked_CGD">Carriers of X-Linked CGD</xref>); and (2) persons with hypomorphic (variant) forms of CGD characterized by partial protein expression/function and residual superoxide production (observed in autosomal recessive CGD and protein-positive X-linked CGD).</p>
              </list-item>
            </list>
            <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="cgd-research_testing.pdf" content-type="local-data">here</inline-supplementary-material> for information about <bold>research testing</bold>.</p>
          </sec>
        </sec>
        <sec id="cgd.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of CGD <bold>is established</bold> in a proband with identification of pathogenic variant(s) in one of five genes that encode the subunits of phagocyte NADPH oxidase (see <xref ref-type="table" rid="cgd.T.summary_of_molecular_genetic_testi">Table 1</xref>).</p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">CYBA</italic>, <italic toggle="yes">NCF1</italic>, <italic toggle="yes">NCF2,</italic> and <italic toggle="yes">NCF4</italic> are the genes in which biallelic pathogenic variants cause autosomal recessive chronic granulomatous disease (AR-CGD).</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">CYBB</italic> is the gene in which a hemizygous pathogenic variant causes X-linked chronic granulomatous disease (X-linked CGD).</p>
            </list-item>
          </list>
          <p>Molecular testing approaches can include <bold>serial single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Serial single-gene testing.</bold> Sequence analysis of the gene of interest is performed first, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found. Of note:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Early-onset, more severe infections and male gender suggest X-linked CGD, and <italic toggle="yes">CYBB</italic> testing may be considered first.</p>
                </list-item>
                <list-item>
                  <p>Later-onset, milder course, female gender and consanguinity suggest autosomal recessive CGD.</p>
                </list-item>
                <list-item>
                  <p>The c.75_76delGT deletion is a common pathogenic variant in <italic toggle="yes">NCF1</italic> (see <xref ref-type="table" rid="cgd.T.summary_of_molecular_genetic_testi">Table 1</xref>); however, <italic toggle="yes">NCF1</italic>-related CDG is not clinically distinguishable from other autosomal recessive forms.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes CYBA, NCF1, NCF2, NCF4, CYBB and other genes of interest (see <xref ref-type="sec" rid="cgd.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and the sensitivity of multi-gene panels vary by laboratory and over time.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, and mitochondrial sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of CGD.</p>
              <p>For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <sec id="cgd.Special_Consideration_in_a_Male_with">
            <title>Special Consideration in a Male with Suspected CGD and Other Medical Issues</title>
            <p>Large deletions in Xp21.1 have been reported in some with X-CGD. Other genes that lie in close proximity to <italic toggle="yes">CYBB</italic> at Xp21.1 include the following [<xref ref-type="bibr" rid="cgd.REF.peng.2007.142">Peng et al 2007</xref>] (see Note):</p>
            <list list-type="bullet">
              <list-item>
                <p><italic toggle="yes">XK</italic>, encoding the Kx blood group (telomeric) associated with <related-object link-type="booklink" source-id="gene" document-id="mcleod" document-type="chapter">McLeod neuroacanthocytosis syndrome</related-object> (deletion of <italic toggle="yes">XK</italic>). This is a multisystem disorder with central nervous system (CNS), neuromuscular, and hematologic manifestations in males. CNS manifestations are a neurodegenerative basal ganglia disease including (1) movement disorder, (2) cognitive impairment, and (3) psychiatric symptoms. Neuromuscular manifestations include a (mostly subclinical) sensorimotor axonopathy and clinically relevant muscle weakness or atrophy. The hematologic manifestations are red blood cell acanthocytosis, compensated hemolysis, and the McLeod blood group phenotype resulting from absent expression of the Kx erythrocyte antigen and reduced expression of the Kell blood group antigens. The Kell blood group system can cause strong reactions to transfusions of incompatible blood and severe anemia in newborns of Kell-negative mothers. Heterozygous females have mosaicism for the Kell system blood group antigens and RBC acanthocytosis but lack CNS and neuromuscular manifestations.</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">RPGR</italic>, encoding retinitis pigmentosa GTPase regulator (telomeric) associated with <related-object link-type="booklink" source-id="gene" document-id="rp-overview" document-type="chapter"><italic toggle="yes">RPGR</italic>-related retinitis pigmentosa</related-object></p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">DMD</italic>, encoding the protein dystrophin (telomeric) associated with <related-object link-type="booklink" source-id="gene" document-id="dbmd" document-type="chapter">Duchenne muscular dystrophy</related-object></p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">OTC</italic>, encoding ornithine transcarbamylase (centromeric) associated with <related-object link-type="booklink" source-id="gene" document-id="otc-def" document-type="chapter">ornithine transcarbamylase deficiency</related-object> (<italic toggle="yes">OTC</italic>) leading to urea cycle defects</p>
              </list-item>
              <list-item>
                <p>Note: Concurrent deletion of <italic toggle="yes">XK</italic> with <italic toggle="yes">CYBB</italic> is the most common; deletion of all five genes is exceedingly rare.</p>
              </list-item>
              <list-item>
                <p>Therefore:</p>
              </list-item>
              <list-item>
                <p>Patients with suspected X-CGD and clinical manifestations of McLeod syndrome, retinitis pigmentosa, Duchenne muscular dystrophy, and/or ornithine transcarbamylase deficiency should have a chromosome microarray analysis (CMA).</p>
              </list-item>
              <list-item>
                <p>If a large deletion is found within <italic toggle="yes">CYBB</italic> , a CMA may be indicated.</p>
              </list-item>
            </list>
            <table-wrap id="cgd.T.summary_of_molecular_genetic_testi" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Chronic Granulomatous Disease</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_1">Gene&#x000a0;<sup>1</sup> / Protein</th>
                    <th id="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_2">Mode of Inheritance</th>
                    <th id="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_3">Proportion of CGD Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detected by Test Method</th>
                  </tr>
                  <tr>
                    <th headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4" id="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>4</sup></th>
                    <th headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4" id="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">CYBA</italic> / p22<sup>phox</sup></td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">6%&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~85%</td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~15%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">NCF1</italic> / p47<sup>phox</sup></td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">20%&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~99%<sup>7</sup></td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~1%&#x000a0;<sup>8</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">NCF2</italic> / p67<sup>pho</sup></td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">6%&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~85%</td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~15%&#x000a0;<sup>9</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">NCF4</italic> / p40<sup>phox</sup></td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">One individual&#x000a0;<sup>10</sup></td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">2/2 alleles</td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">CYBB</italic> / gp91<sup>phox</sup></td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">XL</td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~67%&#x000a0;<sup>11</sup></td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~85%&#x000a0;<sup>12,&#x000a0;13</sup></td>
                    <td headers="hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_cgd.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~15%&#x000a0;<sup>13,&#x000a0;14</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="cgd.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="cgd" object-id="cgd.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="cgd.TF.1.2">
                  <label>2. </label>
                  <p>These rates apply to North America and certain western European populations.</p>
                </fn>
                <fn id="cgd.TF.1.3">
                  <label>3. </label>
                  <p>See <xref ref-type="sec" rid="cgd.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="cgd.TF.1.4">
                  <label>4. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="cgd.TF.1.5">
                  <label>5. </label>
                  <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
                </fn>
                <fn id="cgd.TF.1.6">
                  <label>6. </label>
                  <p>
                    <xref ref-type="bibr" rid="cgd.REF.roos.2010a.291">Roos et al [2010a]</xref>
                  </p>
                </fn>
                <fn id="cgd.TF.1.7">
                  <label>7. </label>
                  <p>By far the most common pathogenic variant in <italic toggle="yes">NCF1</italic> is GT deletion <xref ref-type="table" rid="cgd.T.ncf1_pathogenic_variants_discussed">c.75_76delGT</xref> [<xref ref-type="bibr" rid="cgd.REF.kuhns.2010.2600">Kuhns et al 2010</xref>, <xref ref-type="bibr" rid="cgd.REF.roos.2010a.291">Roos et al 2010a</xref>]. Molecular testing for c.75_76delGT can be complicated by nearby pseudogenes (see <xref ref-type="sec" rid="cgd.Molecular_Genetics">Molecular Genetics</xref>).</p>
                </fn>
                <fn id="cgd.TF.1.8">
                  <label>8. </label>
                  <p>Several large, intragene deletions in <italic toggle="yes">NCF1</italic> have been reported [<xref ref-type="bibr" rid="cgd.REF.roos.2010a.291">Roos et al 2010a</xref>, <xref ref-type="bibr" rid="cgd.REF.roos.2010b.246">Roos et al 2010b</xref>, <xref ref-type="bibr" rid="cgd.REF.raptaki.2013.1302">Raptaki et al 2013</xref>].</p>
                </fn>
                <fn id="cgd.TF.1.9">
                  <label>9. </label>
                  <p><xref ref-type="bibr" rid="cgd.REF.leusen.1996.1243">Leusen et al [1996]</xref>, <xref ref-type="bibr" rid="cgd.REF.gentsch.2010.151">Gentsch et al [2010]</xref>, <xref ref-type="bibr" rid="cgd.REF.roos.2010a.291">Roos et al [2010a]</xref>, <xref ref-type="bibr" rid="cgd.REF.teimourian.2010.587">Teimourian et al [2010]</xref>, <xref ref-type="bibr" rid="cgd.REF.badalzadeh.2012.340">Badalzadeh et al [2012]</xref></p>
                </fn>
                <fn id="cgd.TF.1.10">
                  <label>10. </label>
                  <p>Inactivating pathogenic variants in both <italic toggle="yes">NCF4</italic> alleles were reported in one individual [<xref ref-type="bibr" rid="cgd.REF.matute.2009.3309">Matute et al 2009</xref>]</p>
                </fn>
                <fn id="cgd.TF.1.11">
                  <label>11. </label>
                  <p>
                    <xref ref-type="bibr" rid="cgd.REF.roos.2010b.246">Roos et al [2010b]</xref>
                  </p>
                </fn>
                <fn id="cgd.TF.1.12">
                  <label>12. </label>
                  <p><xref ref-type="bibr" rid="cgd.REF.roos.1996.1663">Roos et al [1996]</xref>, <xref ref-type="bibr" rid="cgd.REF.roos.2010b.246">Roos et al [2010b]</xref></p>
                </fn>
                <fn id="cgd.TF.1.13">
                  <label>13. </label>
                  <p>Lack of amplification by PCR prior to sequence analysis can suggest a putative (multi)exon or whole-gene deletion on the X chromosome in affected males; confirmation requires additional testing by gene-targeted deletion/duplication analysis.</p>
                </fn>
                <fn id="cgd.TF.1.14">
                  <label>14. </label>
                  <p>If a contiguous gene deletion involving multiple genes at Xp21.1 is suspected based on clinical findings, a chromosome microarray analysis (CMA) to detect a microdeletion may be warranted.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
      </sec>
      <sec id="cgd.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="cgd.Clinical_Description">
          <title>Clinical Description</title>
          <p>Chronic granulomatous disease (CGD) is characterized by severe recurrent bacterial and fungal infections and dysregulated inflammatory response resulting in granuloma formation and other inflammatory disorders such as colitis.</p>
          <p>CGD may present any time from infancy to late adulthood; however, the vast majority of affected individuals are diagnosed before age five years. The median age of diagnosis was 2.5 to three years in several series [<xref ref-type="bibr" rid="cgd.REF.jones.2008.211">Jones et al 2008</xref>, <xref ref-type="bibr" rid="cgd.REF.martire.2008.155">Martire et al 2008</xref>]. More recently, increased numbers of affected individuals have been diagnosed in adolescence or adulthood. This delay in diagnosis may be attributed to the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Effective treatment of CGD-related infections with antimicrobials not available in the past</p>
            </list-item>
            <list-item>
              <p>Recognition of milder cases of autosomal recessive (AR) CGD that may have gone undiagnosed without currently available tests and/or awareness of milder disease manifestations</p>
            </list-item>
            <list-item>
              <p>Overall improvement in food handling and sanitation</p>
            </list-item>
          </list>
          <p>Infections and granulomatous lesions are usually the first manifestations of CGD, with the most frequent sites being the lung, lymph nodes, liver and skin. The types of infection seen most often include pneumonia, abscess, adenitis, osteomyelitis, and cellulitis. Other pulmonary complications include empyema and hilar adenopathy. The most common sites for abscesses are the perianal and perirectal areas as well as the liver.</p>
          <p>Although the frequency of infections in persons with CGD has decreased with the routine administration of antibacterial and antifungal prophylaxis, infections still occur at a frequency of 0.3/year.</p>
          <p>In North America, the majority of infections in CGD are caused by <italic toggle="yes">Staphylococcus aureus</italic>, <italic toggle="yes">Burkholderia cepacia</italic> complex, <italic toggle="yes">Serratia marcescens</italic>, <italic toggle="yes">Nocardia</italic> species, and <italic toggle="yes">Aspergillus</italic> species [<xref ref-type="bibr" rid="cgd.REF.marciano.2015.1176">Marciano et al 2015</xref>] (<xref ref-type="table" rid="cgd.T.infections_in_cgd_common_pathogens">Table 2</xref>). In other parts of the world important causes of infection are <italic toggle="yes">Salmonella</italic>, bacille Calmette-Gu&#x000e9;rin (BCG), and tuberculosis [<xref ref-type="bibr" rid="cgd.REF.winkelstein.2000.155">Winkelstein et al 2000</xref>, <xref ref-type="bibr" rid="cgd.REF.van_den_berg.2009.e5234">van den Berg et al 2009</xref>].</p>
          <table-wrap id="cgd.T.infections_in_cgd_common_pathogens" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Infections in CGD: Common Pathogens and Sites of Involvement</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Pathogen</th>
                  <th id="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Presentation</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" rowspan="7" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Bacterial</bold>
                    <break/>
                    <bold>infections</bold>
                  </td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">Staphylococcus aureus</italic>
                  </td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Soft tissue infections<break/>Lymphadenitis<break/>Liver abscess<break/>Osteomyelitis<break/>Pneumonia<break/>Sepsis</td>
                </tr>
                <tr>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1"><italic toggle="yes">Burkholderia</italic> species&#x000a0;<sup>1</sup>
<list list-type="bullet"><list-item><p><italic toggle="yes">B. cepacia</italic>&#x000a0;<sup>2</sup></p></list-item><list-item><p><italic toggle="yes">B. gladioli</italic></p></list-item><list-item><p><italic toggle="yes">B. pseudomallei</italic></p></list-item></list>
</td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Pneumonia<break/>Sepsis</td>
                </tr>
                <tr>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1"><italic toggle="yes">Serratia marcescens</italic>&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">More common:
<list list-type="bullet"><list-item><p>Osteomyelitis</p></list-item><list-item><p>Soft tissue infections</p></list-item></list>
Less common:
<list list-type="bullet"><list-item><p>Pneumonia</p></list-item><list-item><p>Sepsis</p></list-item></list>
</td>
                </tr>
                <tr>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1"><italic toggle="yes">Nocardia</italic> species&#x000a0;<sup>4,&#x000a0;5</sup>
<list list-type="bullet"><list-item><p><italic toggle="yes">N. asteroides</italic></p></list-item><list-item><p><italic toggle="yes">N. nova</italic></p></list-item><list-item><p><italic toggle="yes">N. otitidiscaviarum</italic></p></list-item><list-item><p><italic toggle="yes">N. farcinica</italic></p></list-item></list>
</td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Pneumonia<break/>Osteomyelitis<break/>Brain abscess</td>
                </tr>
                <tr>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1"><list list-type="bullet"><list-item><p><italic toggle="yes">Granulibacter bethesdensis</italic>&#x000a0;<sup>6</sup></p></list-item></list>
</td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Necrotizing lymphadenitis<break/>Sepsis<break/>Meningitis</td>
                </tr>
                <tr>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1"><list list-type="bullet"><list-item><p><italic toggle="yes">Chromobacterium violaceum</italic>&#x000a0;<sup>7</sup></p></list-item></list>
</td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sepsis</td>
                </tr>
                <tr>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1"><list list-type="bullet"><list-item><p><italic toggle="yes">Francisella philomiragia</italic>&#x000a0;<sup>8</sup></p></list-item></list>
</td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sepsis</td>
                </tr>
                <tr>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Fungal</bold>
                    <break/>
                    <bold>infections&#x000a0;<sup>9</sup></bold>
                  </td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus</italic> species
<list list-type="bullet"><list-item><p><italic toggle="yes">A. fumigatus</italic></p></list-item><list-item><p><italic toggle="yes">A. nidulans</italic></p></list-item><list-item><p><italic toggle="yes">A. viridinutans</italic></p></list-item><list-item><p><italic toggle="yes">A. flavus</italic></p></list-item><list-item><p><italic toggle="yes">A. terreus</italic></p></list-item><list-item><p><italic toggle="yes">A. niger</italic></p></list-item></list>
</td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Pneumonia<break/>Osteomyelitis<break/>Brain abscess<break/>Lymphadenitis</td>
                </tr>
                <tr>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1"><italic toggle="yes">Paecilomyces</italic> species
<list list-type="bullet"><list-item><p><italic toggle="yes">P. variotti</italic></p></list-item><list-item><p><italic toggle="yes">P. lilacinus</italic></p></list-item></list>
</td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Pneumonia<break/>Soft tissue infections<break/>Osteomyelitis</td>
                </tr>
                <tr>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Other molds
<list list-type="bullet"><list-item><p><italic toggle="yes">Geosmitha argillacea</italic>&#x000a0;<sup>10</sup></p></list-item><list-item><p><italic toggle="yes">Cephalosporum species</italic></p></list-item><list-item><p><italic toggle="yes">Chaetomium strumarium</italic></p></list-item><list-item><p><italic toggle="yes">Phialophora richardsiae</italic></p></list-item><list-item><p><italic toggle="yes">Scedosporium apiospermum</italic></p></list-item><list-item><p><italic toggle="yes">Exophiala species</italic></p></list-item><list-item><p><italic toggle="yes">Cladosporium species</italic></p></list-item><list-item><p><italic toggle="yes">Zygomycete species</italic></p></list-item><list-item><p><italic toggle="yes">Acremonium species</italic></p></list-item><list-item><p><italic toggle="yes">Neosartorya udagawae</italic></p></list-item><list-item><p><italic toggle="yes">Phellinus species</italic>&#x000a0;<sup>11</sup></p></list-item></list>
</td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Pneumonia<break/>Soft tissue infection</td>
                </tr>
                <tr>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Yeast</bold>
                    <break/>
                    <bold>infections</bold>
                  </td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">Candida
<list list-type="bullet"><list-item><p><italic toggle="yes">C. albicans</italic></p></list-item><list-item><p><italic toggle="yes">C. glabrata</italic></p></list-item><list-item><p><italic toggle="yes">C. lusitaniae</italic></p></list-item></list>
</td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sepsis<break/>Soft tissue infection<break/>Liver abscess</td>
                </tr>
                <tr>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_1" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Trichosporon
<list list-type="bullet"><list-item><p><italic toggle="yes">T. beigeli</italic></p></list-item><list-item><p><italic toggle="yes">T. inkin</italic></p></list-item></list>
<italic toggle="yes">Arthrographis kalrae</italic></td>
                  <td headers="hd_h_cgd.T.infections_in_cgd_common_pathogens_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Pneumonia<break/>Soft tissue infection</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="cgd.TF.2.1">
                <label>1. </label>
                <p>
                  <xref ref-type="bibr" rid="cgd.REF.greenberg.2009.1577">Greenberg et al [2009]</xref>
                </p>
              </fn>
              <fn id="cgd.TF.2.2">
                <label>2. </label>
                <p><italic toggle="yes">B. cepacia</italic> is also a cause of pneumonia in <related-object link-type="booklink" source-id="gene" document-id="cf" document-type="chapter">cystic fibrosis</related-object>.</p>
              </fn>
              <fn id="cgd.TF.2.3">
                <label>3. </label>
                <p><xref ref-type="bibr" rid="cgd.REF.galluzzo.2008.745">Galluzzo et al [2008]</xref>, <xref ref-type="bibr" rid="cgd.REF.friend.2009.164">Friend et al [2009]</xref></p>
              </fn>
              <fn id="cgd.TF.2.4">
                <label>4. </label>
                <p>
                  <xref ref-type="bibr" rid="cgd.REF.dorman.2002.390">Dorman et al [2002]</xref>
                </p>
              </fn>
              <fn id="cgd.TF.2.5">
                <label>5. </label>
                <p>Outside of CGD <italic toggle="yes">Nocardia</italic> infections occur predominantly in the setting of high-dose corticosteroids.</p>
              </fn>
              <fn id="cgd.TF.2.6">
                <label>6. </label>
                <p>
                  <xref ref-type="bibr" rid="cgd.REF.greenberg.2006.e28">Greenberg et al [2006]</xref>
                </p>
              </fn>
              <fn id="cgd.TF.2.7">
                <label>7. </label>
                <p>
                  <xref ref-type="bibr" rid="cgd.REF.sirinavin.2005.559">Sirinavin et al [2005]</xref>
                </p>
              </fn>
              <fn id="cgd.TF.2.8">
                <label>8. </label>
                <p>
                  <xref ref-type="bibr" rid="cgd.REF.mailman.2005.245">Mailman &#x00026; Schmidt [2005]</xref>
                </p>
              </fn>
              <fn id="cgd.TF.2.9">
                <label>9. </label>
                <p><xref ref-type="bibr" rid="cgd.REF.beaut_.2011.57">Beaut&#x000e9; et al [2011]</xref>, <xref ref-type="bibr" rid="cgd.REF.blumental.2011.e159">Blumental et al [2011]</xref></p>
              </fn>
              <fn id="cgd.TF.2.10">
                <label>10. </label>
                <p>
                  <xref ref-type="bibr" rid="cgd.REF.de_ravin.2011.e136">De Ravin et al [2011]</xref>
                </p>
              </fn>
              <fn id="cgd.TF.2.11">
                <label>11. </label>
                <p><xref ref-type="bibr" rid="cgd.REF.de_ravin.2014.2726">De Ravin et al [2014]</xref>, <xref ref-type="bibr" rid="cgd.REF.ramesh.2014.130">Ramesh et al [2014]</xref>, <xref ref-type="bibr" rid="cgd.REF.shigemura.2015.371">Shigemura et al [2015]</xref></p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <sec id="cgd.Bacterial_Infections">
            <title>Bacterial Infections</title>
            <p>Widespread prophylaxis has limited staphylococcal infections primarily to the skin, lymph nodes, liver, and (rarely) the lung [<xref ref-type="bibr" rid="cgd.REF.marciano.2015.1176">Marciano et al 2015</xref>].</p>
            <p><italic toggle="yes">Burkholderia cepacia</italic> complex infection is common in patients with CGD and can occasionally cause sepsis.</p>
            <p>Outside of CGD <italic toggle="yes">Nocardia</italic> infections occur predominantly in the setting of high-dose corticosteroids.</p>
            <p>Mycobacterial diseases in CGD are mostly limited to regional and disseminated BCG infections and tuberculosis. Persons with CGD are less susceptible to nontuberculous infections than persons with defects in T cell or interferon gamma/IL-12 pathways: in persons with CGD, BCG infection may cause severe localized disease such as draining skin lesions at sites of BCG vaccination [<xref ref-type="bibr" rid="cgd.REF.lee.2008.224">Lee et al 2008</xref>], whereas in persons with severe combined immunodeficiency or defects in the IFN-gamma receptor pathway BCG infection typically causes disseminated disease.</p>
            <p>Uncommon bacterial infections that are virtually pathognomonic for CGD include:</p>
            <list list-type="bullet">
              <list-item>
                <p><italic toggle="yes">Granulibacter bethesdensis</italic>, which causes necrotizing lymphadenitis, sepsis, and meningitis [<xref ref-type="bibr" rid="cgd.REF.greenberg.2006.e28">Greenberg et al 2006</xref>];</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">Chromobacterium violaceum</italic>, which is found in brackish waters such as the Gulf of Mexico and causes sepsis [<xref ref-type="bibr" rid="cgd.REF.sirinavin.2005.559">Sirinavin et al 2005</xref>];</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">Francisella philomiragia</italic>, which is also found in brackish waters such as the Chesapeake Bay and is a cause of sepsis [<xref ref-type="bibr" rid="cgd.REF.mailman.2005.245">Mailman &#x00026; Schmidt 2005</xref>].</p>
              </list-item>
            </list>
            <p>Bacteremia is relatively uncommon except with certain gram-negative organisms.</p>
          </sec>
          <sec id="cgd.Fungal_Infections">
            <title>Fungal Infections</title>
            <p>Invasive fungal infections, which have the highest prevalence in CGD among all primary immunodeficiencies, remain the leading cause of mortality in CGD. They occur most commonly in the first two decades of life and can be a first presentation of disease [<xref ref-type="bibr" rid="cgd.REF.marciano.2015.1176">Marciano et al 2015</xref>]; about 30% of individuals with CGD will develop fungal infections [<xref ref-type="bibr" rid="cgd.REF.beaut_.2011.57">Beaut&#x000e9; et al 2011</xref>, <xref ref-type="bibr" rid="cgd.REF.marciano.2015.1176">Marciano et al 2015</xref>].</p>
            <p>Fungal infections are typically acquired through inhalation of spores or hyphae resulting in pneumonia that can spread locally to the ribs and spine or metastatically to the brain. Presentation may be insidious with symptoms that are absent or manifest as failure to thrive and malaise. Other common presenting signs and symptoms include cough, fever, and chest pain.</p>
            <p><italic toggle="yes">Aspergillus</italic> species are the most common cause of invasive fungal infections, typically in the lung.</p>
            <list list-type="bullet">
              <list-item>
                <p><italic toggle="yes">Aspergillus fumigatus</italic> is the most common of the <italic toggle="yes">Aspergillus</italic> species to cause infection in CGD. Although angioinvasion is common in neutropenic settings, it does not occur in CGD.</p>
              </list-item>
              <list-item>
                <p><italic toggle="yes">Aspergillus nidulans</italic> infection is almost exclusive to CGD and causes more severe and refractory disease with local and distant spread [<xref ref-type="bibr" rid="cgd.REF.segal.1998.345">Segal et al 1998</xref>, <xref ref-type="bibr" rid="cgd.REF.beaut_.2011.57">Beaut&#x000e9; et al 2011</xref>].</p>
              </list-item>
            </list>
            <p><italic toggle="yes">Paecilomyces lilacinus</italic> and <italic toggle="yes">Paecilomyces variotti</italic> cause pneumonia and osteomyelitis in CGD almost exclusively.</p>
            <p>Mucormycosis has been reported in CGD but appear to occur only in the setting of significant immunosuppression [<xref ref-type="bibr" rid="cgd.REF.vinh.2009.1411">Vinh et al 2009</xref>].</p>
            <p>The overall frequency and mortality of invasive fungal infections have been significantly reduced with the use of itraconazole as antifungal prophylaxis and the use of other azoles (voriconazole and posaconazole) as therapy. However, when they occur, fungal infections develop at an older age and may require longer duration of therapy. Fungal infections cause more mortality than other infections in CGD [<xref ref-type="bibr" rid="cgd.REF.marciano.2015.1176">Marciano et al 2015</xref>]. An increased frequency of infection with <italic toggle="yes">Aspergillus nidulans</italic> and other opportunistic fungi may be associated with itraconazole prophylaxis [<xref ref-type="bibr" rid="cgd.REF.blumental.2011.e159">Blumental et al 2011</xref>].</p>
            <p>Yeast infections are not nearly as common as bacterial and fungal infections in persons with CGD; mucocutaneous candidiasis is not encountered.</p>
            <p>Note: The endemic dimorphic mold infections histoplasmosis, blastomycosis, and coccidioidomycosis do not occur in CGD [<xref ref-type="bibr" rid="cgd.REF.holland.2010.3">Holland 2010</xref>].</p>
          </sec>
          <sec id="cgd.Inflammatory_and_Other_Manifestation">
            <title>Inflammatory and Other Manifestations</title>
            <p>Formation of granulomata and dysregulated inflammation in CGD contribute to morbidity and can cause multiple symptoms. The genitourinary and gastrointestinal tracts are most commonly affected.</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Genitourinary manifestations</bold> include bladder granulomata that are associated with ureteral obstruction and urinary tract infections. Other manifestations include pseudotumors of the bladder and eosinophilic cystitis.</p>
              </list-item>
              <list-item>
                <p>
                  <bold>Gastrointestinal manifestations</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Pyloric edema leads to functional gastric outlet obstruction and can be an initial presentation of CGD.</p>
                  </list-item>
                  <list-item>
                    <p>Esophageal, jejunal, ileal, cecal, rectal, and perirectal granulomata similar to those in Crohn disease have also been described. Symptomatic inflammatory bowel disease affects up to 50% of affected individuals and can be the presenting finding [<xref ref-type="bibr" rid="cgd.REF.marciano.2004.462">Marciano et al 2004</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>Other gastrointestinal symptoms indicative of CGD colitis include abdominal pain, diarrhea, strictures, and fistulae. Significant colitis leading to bowel obstruction, fistulae, and strictures can be an important cause of growth retardation [<xref ref-type="bibr" rid="cgd.REF.marciano.2004.462">Marciano et al 2004</xref>].</p>
                  </list-item>
                </list>
              </list-item>
            </list>
            <p><bold>Liver involvement</bold> is a significant cause of morbidity in CGD, with abscesses occurring in up to 35% of affected individuals. Liver abscesses have been difficult to cure without surgery and carry a significant risk for recurrence, but not relapse [<xref ref-type="bibr" rid="cgd.REF.hussain.2007.675">Hussain et al 2007</xref>].</p>
            <p>Other common liver abnormalities include liver enzyme elevation, persistent elevations in alkaline phosphatase, and drug-induced hepatitis.</p>
            <p>High rates of portal venopathy are associated with splenomegaly and nodular regenerative hyperplasia. Portal hypertension and thrombocytopenia are associated with intrahepatic disease and important risk factors for mortality [<xref ref-type="bibr" rid="cgd.REF.hussain.2007.675">Hussain et al 2007</xref>, <xref ref-type="bibr" rid="cgd.REF.feld.2008.1917">Feld et al 2008</xref>].</p>
            <p><bold>Hyperinflammation</bold> is seen, especially in response to infectious agents. The exact etiology of dysregulated inflammation in CGD is unclear. Heightened inflammatory response has been described in chronic colitis [<xref ref-type="bibr" rid="cgd.REF.marciano.2004.462">Marciano et al 2004</xref>], granulomatous cystitis [<xref ref-type="bibr" rid="cgd.REF.kontras.1971.575">Kontras et al 1971</xref>], pulmonary infections with <italic toggle="yes">Nocardia</italic> [<xref ref-type="bibr" rid="cgd.REF.freeman.2011.806">Freeman et al 2011</xref>], and staphylococcal liver abscesses [<xref ref-type="bibr" rid="cgd.REF.yamazakinakashimada.2006.257">Yamazaki-Nakashimada et al 2006</xref>, <xref ref-type="bibr" rid="cgd.REF.leiding.2012.694">Leiding et al 2012</xref>].</p>
            <p>Fungi elicit an exuberant inflammatory response regardless of whether the fungi are alive or dead [<xref ref-type="bibr" rid="cgd.REF.morgenstern.1997.207">Morgenstern et al 1997</xref>] as in &#x02018;mulch pneumonitis,&#x02019; a syndrome caused by inhalation of aerosolized decayed organic matter (e.g., hay, dead leaves) [<xref ref-type="bibr" rid="cgd.REF.siddiqui.2007.673">Siddiqui et al 2007</xref>]. Acute fulminant pneumonitis (similar to that seen in hypersensitivity pneumonitis) ensues.</p>
            <p>Prolonged and dysregulated inflammation in CGD can overlap clinically with the syndrome of <related-object link-type="booklink" source-id="gene" document-id="hlh" document-type="chapter">hemophagocytic lymphohistiocytosis</related-object> (HLH). HLH is caused by an ineffective and unrestrained inflammatory response by T lymphocytes, NK cells, and macrophages leading to fever, hepatosplenomegaly, cytopenias, and hemophagocytosis in the bone marrow and other tissues. Persons with CGD can develop prolonged fever and most of the clinical features of HLH.</p>
            <p><bold>Growth retardation</bold> is common in CGD and failure to thrive can be a common presenting finding [<xref ref-type="bibr" rid="cgd.REF.marciano.2004.462">Marciano et al 2004</xref>]. Growth failure can be compounded by colitis. Growth may improve in late adolescence and many affected individuals may attain appropriate adult height and weight, albeit on the lower end of the spectrum.</p>
            <p><bold>Chronic respiratory disease</bold> can result from recurrent infection. Bronchiectasis, obliterative bronchiolitis, and chronic fibrosis may occur but are not as common as in some other primary immunodeficiencies.</p>
            <p><bold>Ophthalmic manifestations</bold> include chorioretinal lesions and granulomata with pigment clumping that are usually asymptomatic but often associated with recovery of bacterial DNA from retinal tissue samples [<xref ref-type="bibr" rid="cgd.REF.wang.2013.917">Wang et al 2013</xref>]. Inflammatory eye disease including keratitis and uveitis can occur as well.</p>
            <p><bold>Oral manifestations</bold> include gingivitis, stomatitis, aphthous ulceration, and gingival hypertrophy.</p>
            <p><bold>Non-infectious skin manifestations</bold> include photosensitivity, granulomatous lesions, vasculitis, and excessive inflammation at drainage and surgical wounds leading to dehiscence.</p>
            <p><bold>Autoimmune disorders</bold> are common. Autoimmune diseases reported in individuals with CGD include idiopathic thrombocytopenic purpura, juvenile idiopathic arthritis, autoimmune pulmonary disease, myasthenia gravis, IgA nephropathy, antiphospholipid syndrome, and recurrent pericardial effusion [<xref ref-type="bibr" rid="cgd.REF.winkelstein.2000.155">Winkelstein et al 2000</xref>, <xref ref-type="bibr" rid="cgd.REF.de_ravin.2008.1097">De Ravin et al 2008</xref>].</p>
            <p><bold>Malignancies</bold> have been reported in CGD, and may be more common in autosomal recessive CGD than in X-linked CGD, raising the possibility that the increased incidence of malignancy is due to other cosegregating autosomal recessive traits [<xref ref-type="bibr" rid="cgd.REF.aguilera.2009.965">Aguilera et al 2009</xref>, <xref ref-type="bibr" rid="cgd.REF.geramizadeh.2010.319">Geramizadeh et al 2010</xref>, <xref ref-type="bibr" rid="cgd.REF.lugo_reyes.2011.543">Lugo Reyes et al 2011</xref>].</p>
            <p>The histopathologic patterns of malignancy have significant overlap with certain chronic inflammatory conditions. However, the largest series to date reported no malignancies [<xref ref-type="bibr" rid="cgd.REF.winkelstein.2000.155">Winkelstein et al 2000</xref>, <xref ref-type="bibr" rid="cgd.REF.van_den_berg.2009.e5234">van den Berg et al 2009</xref>]. Smaller, more recent series corroborate a low overall incidence of malignancy [<xref ref-type="bibr" rid="cgd.REF.k_ker.2013.1156">K&#x000f6;ker et al 2013</xref>, <xref ref-type="bibr" rid="cgd.REF.raptaki.2013.1302">Raptaki et al 2013</xref>, <xref ref-type="bibr" rid="cgd.REF.baba.2014.452">Baba et al 2014</xref>, <xref ref-type="bibr" rid="cgd.REF.alzadjali.2015.185">Al-Zadjali et al 2015</xref>].</p>
            <p><bold>Survival in CGD</bold> has improved greatly, and is now approximately 90% at age ten years [<xref ref-type="bibr" rid="cgd.REF.jones.2008.211">Jones et al 2008</xref>, <xref ref-type="bibr" rid="cgd.REF.martire.2008.155">Martire et al 2008</xref>, <xref ref-type="bibr" rid="cgd.REF.kuhns.2010.2600">Kuhns et al 2010</xref>, <xref ref-type="bibr" rid="cgd.REF.marciano.2015.1176">Marciano et al 2015</xref>]. Overall rates of survival are lower among those with X-linked CGD than those with autosomal recessive CGD.</p>
            <p>Survival is influenced by several factors:</p>
            <list list-type="bullet">
              <list-item>
                <p>Residual superoxide production, which correlates most directly with overall survival [<xref ref-type="bibr" rid="cgd.REF.kuhns.2010.2600">Kuhns et al 2010</xref>] (see <xref ref-type="sec" rid="cgd.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>):</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Persons with <italic toggle="yes">NCF1</italic> pathogenic variants have relatively good overall survival (&#x0003e;80% beyond age 40 years), which is similar to the survival rate in persons with <italic toggle="yes">CYBB</italic> pathogenic missense variants associated with residual superoxide production.</p>
                  </list-item>
                  <list-item>
                    <p>Persons with <italic toggle="yes">CYBB</italic> pathogenic variants that result in no superoxide production have a survival of approximately 55% beyond age 40 years.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>Use of azoles for antifungal prophylaxis and therapy. Several series [<xref ref-type="bibr" rid="cgd.REF.jones.2008.211">Jones et al 2008</xref>, <xref ref-type="bibr" rid="cgd.REF.kobayashi.2008.1389">Kobayashi et al 2008</xref>, <xref ref-type="bibr" rid="cgd.REF.martire.2008.155">Martire et al 2008</xref>, <xref ref-type="bibr" rid="cgd.REF.marciano.2015.1176">Marciano et al 2015</xref>] report increased survival rates over the past 20 years:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>88%-97% at age 10 years</p>
                  </list-item>
                  <list-item>
                    <p>73%-87% at age 20 years</p>
                  </list-item>
                  <list-item>
                    <p>46%-55% at age 30 years</p>
                    <p>Note: Patients diagnosed and treated before the use of azoles usually did not survive past age 30-40 years.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>Access to care and expertise of caregivers</p>
              </list-item>
              <list-item>
                <p>Post-infectious complications such as hepatic nodular regenerative hyperplasia and portal venopathy associated with liver abscess, which contribute to overall morbidity and mortality [<xref ref-type="bibr" rid="cgd.REF.marciano.2004.462">Marciano et al 2004</xref>, <xref ref-type="bibr" rid="cgd.REF.hussain.2007.675">Hussain et al 2007</xref>, <xref ref-type="bibr" rid="cgd.REF.feld.2008.1917">Feld et al 2008</xref>]</p>
              </list-item>
            </list>
            <p>Note: Inflammatory bowel disease does not influence mortality: overall survival rates of persons with CGD with and without colitis are similar [<xref ref-type="bibr" rid="cgd.REF.marciano.2004.462">Marciano et al 2004</xref>, <xref ref-type="bibr" rid="cgd.REF.kuhns.2010.2600">Kuhns et al 2010</xref>, <xref ref-type="bibr" rid="cgd.REF.marciano.2015.1176">Marciano et al 2015</xref>].</p>
            <p><bold>Hypomorphic (variant) CGD</bold> is characterized by partial protein expression/function and residual superoxide production (observed in autosomal recessive CGD and protein-positive X-linked CGD). Affected individuals typically have a milder course and come to clinical attention later in life than those with absent protein expression [<xref ref-type="bibr" rid="cgd.REF.bender.2009.529">Bender et al 2009</xref>].</p>
          </sec>
          <sec id="cgd.Carriers_of_XLinked_CGD">
            <title>Carriers of X-Linked CGD</title>
            <p>Female carriers of a <italic toggle="yes">CYBB</italic> pathogenic variant are typically unaffected, as the amount of gp91<italic toggle="yes"><sup>phox</sup></italic> produced by their normal <italic toggle="yes">CYBB</italic> allele allows adequate superoxide production. However, some women are affected because they express primarily the <italic toggle="yes">CYBB</italic> disease-causing allele as the result of skewed (non-random) X-chromosome inactivation. These women may develop clinical evidence of CGD [<xref ref-type="bibr" rid="cgd.REF.johnston.1985.50">Johnston 1985</xref>, <xref ref-type="bibr" rid="cgd.REF.andersoncohen.2003.308">Anderson-Cohen et al 2003</xref>]:</p>
            <list list-type="bullet">
              <list-item>
                <p>The most common findings are cutaneous lesions resembling discoid lupus and recurrent aphthous stomatitis [<xref ref-type="bibr" rid="cgd.REF.hafner.1992.446">Hafner et al 1992</xref>].</p>
              </list-item>
              <list-item>
                <p>In a prospective study of 19 women known to carry a <italic toggle="yes">CYBB</italic> pathogenic variant, <xref ref-type="bibr" rid="cgd.REF.cale.2007.79">Cale et al [2007]</xref> found a history of photosensitive skin rashes (58%), mouth ulcers (42%), and joint pain (37%). Most of these women had negative lupus serology.</p>
              </list-item>
              <list-item>
                <p>Chorioretinal lesions and granulomata with pigment clumping that are usually asymptomatic have been detected in females who are carriers of a <italic toggle="yes">CYBB</italic> pathogenic variant [<xref ref-type="bibr" rid="cgd.REF.wang.2013.917">Wang et al 2013</xref>].</p>
              </list-item>
              <list-item>
                <p><xref ref-type="bibr" rid="cgd.REF.lewis.2008.372">Lewis et al [2008]</xref> reported a female age 16 years with X-linked CGD in whom methylation analysis demonstrated skewed X-chromosome inactivation resulting in expression of the <italic toggle="yes">CYBB</italic> pathogenic variant inherited from her mother.</p>
              </list-item>
              <list-item>
                <p><xref ref-type="bibr" rid="cgd.REF.gono.2008.1053">Gono et al [2008]</xref> reported a woman age 28 years with CGD resulting from a <italic toggle="yes">de novo</italic>
<italic toggle="yes">CYBB</italic> pathogenic variant on her paternally inherited X chromosome and skewed X-chromosome inactivation of her maternally inherited X chromosome.</p>
              </list-item>
              <list-item>
                <p><xref ref-type="bibr" rid="cgd.REF.wolach.2005.61">Wolach et al [2005]</xref> report somatic mosaicism for a <italic toggle="yes">CYBB</italic> pathogenic variant in a woman with findings consistent with X-linked CGD at age 66 years. They suggested that the pathogenic variant probably originated in her bone marrow.</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="cgd.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Historically, it has been recognized that pathogenic variants in <italic toggle="yes">CYBB</italic> (the cause of X-linked CGD) give rise to a more serious phenotype than pathogenic variants causing autosomal recessive (AR) forms of CGD. Compared to persons with AR-CGD, males with X-linked CGD are typically diagnosed earlier and have a significantly higher incidence of perirectal abscess, suppurative adenitis, gastric outlet obstruction, urinary obstruction, and higher mortality at a young age.</p>
          <p>Genotype-phenotype correlations in the X-linked gene <italic toggle="yes">CYBB</italic> (encoding gp91<sup>phox</sup>) include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>All nonsense variants or deletions of <italic toggle="yes">CYBB</italic> in males are highly deleterious and associated with poorer outcomes.</p>
            </list-item>
            <list-item>
              <p>Pathogenic missense variants that occur in the <italic toggle="yes">CYBB</italic> region encoding amino acids 1-309 are associated with residual superoxide production at a level sufficient for good overall survival. Exceptions are pathogenic variants in the nucleotides encoding histidine at residue 222, which do not support production of residual superoxide and, therefore, are more deleterious.</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">CYBB</italic> regions encoding amino acid residues 310 and beyond affect the FAD- and NADPH-binding domains that are essential for superoxide function. Even when pathogenic variants in this region allow protein expression, the proteins are nonfunctional and associated with poorer overall outcomes in affected males. Therefore, protein expression is neither reliable nor useful as a predictor of residual superoxide production [<xref ref-type="bibr" rid="cgd.REF.kuhns.2010.2600">Kuhns et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>The phenotype caused by pathogenic variants in <italic toggle="yes">CYBB</italic> associated with residual superoxide production is characterized by better survival than with <italic toggle="yes">CYBB</italic> variants that cause no residual superoxide production.</p>
            </list-item>
            <list-item>
              <p>Of note, the occurrence of inflammatory bowel disease in CGD is not correlated with superoxide production or mortality [<xref ref-type="bibr" rid="cgd.REF.bender.2009.529">Bender et al 2009</xref>, <xref ref-type="bibr" rid="cgd.REF.kuhns.2010.2600">Kuhns et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="cgd.REF.kuhns.2010.2600">Kuhns et al [2010]</xref> detemined that the level of residual neutrophil superoxide production influences morbidity and survival rates in persons with CGD. The production of reactive oxygen intermediates (ROI) was measured using the cytochrome <italic toggle="yes">c</italic> reduction assay (see <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="cgd-research_testing.pdf" content-type="local-data">Research testing</inline-supplementary-material>) and the DHR test (see Diagnosis, <xref ref-type="sec" rid="cgd.Laboratory_testing">Laboratory testing</xref>). Protein expression was determined using the immunoblot test for the NADPH complex proteins (see <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="cgd-research_testing.pdf" content-type="local-data">Research testing</inline-supplementary-material>). Persons with modest ROI production have less severe illness and higher long-term survival than those with little ROI production.</p>
            </list-item>
            <list-item>
              <p>ROI production may be predicted by the specific pathogenic variant type and gene:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Lower ROI production is associated with decreased survival and was observed in persons with deletions and nonsense, frameshift, and some splice variants.</p>
                </list-item>
                <list-item>
                  <p>Higher ROI production and increased survival were observed in persons with <italic toggle="yes">CYBB</italic> pathogenic missense variants between amino acids 1 and 309 (with the exception of histidine 222) or pathogenic variants in <italic toggle="yes">NCF1</italic> [<xref ref-type="bibr" rid="cgd.REF.kuhns.2010.2600">Kuhns et al 2010</xref>].</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Complete <italic toggle="yes">CYBA</italic> pathogenic variants lead to absent protein expression and thereby disable the formation of the cytochrome complex. These variants therefore behave like the most deleterious of the <italic toggle="yes">CYBB</italic> pathogenic variants.</p>
        </sec>
        <sec id="cgd.Nomenclature">
          <title>Nomenclature</title>
          <p>When first characterized, chronic granulomatous disease was called &#x0201c;fatal granulomatous disease of childhood&#x0201d; [<xref ref-type="bibr" rid="cgd.REF.bridges.1959.387">Bridges et al 1959</xref>].</p>
        </sec>
        <sec id="cgd.Prevalence">
          <title>Prevalence</title>
          <p>The retrospectively and voluntarily reported prevalence of CGD is approximately 1:200,000 live births in the United States [<xref ref-type="bibr" rid="cgd.REF.winkelstein.2000.155">Winkelstein et al 2000</xref>].</p>
          <p>Prevalence rates in other countries vary somewhat based on social, religious, and cultural factors that influence birth rates and frequency of consanguinity [<xref ref-type="bibr" rid="cgd.REF.wolach.2008.103">Wolach et al 2008</xref>, <xref ref-type="bibr" rid="cgd.REF.fattahi.2011.792">Fattahi et al 2011</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Sweden: 1:450,000 [<xref ref-type="bibr" rid="cgd.REF.ahlin.1995.1386">Ahlin et al 1995</xref>]</p>
            </list-item>
            <list-item>
              <p>Japan: 1:300,000 [<xref ref-type="bibr" rid="cgd.REF.hasui.1999.589">Hasui &#x00026; Japa 1999</xref>]</p>
            </list-item>
            <list-item>
              <p>United Kingdom: 1:133,000 [<xref ref-type="bibr" rid="cgd.REF.jones.2008.211">Jones et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>Israel [<xref ref-type="bibr" rid="cgd.REF.wolach.2008.103">Wolach et al 2008</xref>]</p>
              <list list-type="bullet">
                <list-item>
                  <p>Arabs: 1:111,000</p>
                </list-item>
                <list-item>
                  <p>Jews: 1:218,000</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Italy: 1:1,000,000 [<xref ref-type="bibr" rid="cgd.REF.martire.2008.155">Martire et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>Greece: 2.2:100,000 [<xref ref-type="bibr" rid="cgd.REF.raptaki.2013.1302">Raptaki et al 2013</xref>]</p>
            </list-item>
          </list>
          <p>Importantly, in regions with high rates of consanguineous marriages, the prevalence of recessive forms of CGD exceeds that of X-linked CGD.</p>
        </sec>
      </sec>
      <sec id="cgd.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">CYBA</italic>, <italic toggle="yes">NCF1</italic>, <italic toggle="yes">NCF2</italic>, <italic toggle="yes">NCF4</italic>.</bold> No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of these four genes.</p>
        <p><bold><italic toggle="yes">CYBB</italic>.</bold> Two <italic toggle="yes">CYBB</italic> pathogenic missense variants, NM_000397.3:c.692A&#x0003e;C (p.Gln231Pro) and c.532A&#x0003e;C (p.Thr178Pro), have been associated with susceptibility to extrapulmonary mycobacterial disease due to BCG in two kindreds. The respiratory burst in macrophages was impaired, whereas monocytes and neutrophils showed no dysfunction [<xref ref-type="bibr" rid="cgd.REF.bustamante.2011.213">Bustamante et al 2011</xref>].</p>
      </sec>
      <sec id="cgd.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of chronic granulomatous disease (CGD) mainly involves disorders with recurrent or unusual infections or disorders associated with granuloma formation and hyperinflammation. The following disorders should be considered.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="cf" document-type="chapter"><bold>Cystic fibrosis</bold></related-object><bold>.</bold> Individuals with cystic fibrosis may develop pulmonary infections with <italic toggle="yes">Burkholderia cepacia</italic> complex. Unlike in CGD, these infections are typically isolated to the lung and occur concurrently with significant bronchiectasis. Individuals with CGD are prone to recurrent infection with different strains of <italic toggle="yes">Burkholderia cepacia</italic> complex<italic toggle="yes">,</italic> whereas those with cystic fibrosis are often persistently infected with the same strain [<xref ref-type="bibr" rid="cgd.REF.greenberg.2009.1577">Greenberg et al 2009</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="higes" document-type="chapter"><bold>Hyper IgE syndrome</bold></related-object><bold>.</bold> Staphylococcal and <italic toggle="yes">Aspergillus</italic> infections are common in individuals with autosomal dominant STAT3-deficient hyper IgE syndrome (AD-HIES). However, those with AD-HIES also have characteristic facies, skeletal abnormalities, and markedly elevated IgE levels [<xref ref-type="bibr" rid="cgd.REF.freeman.2009.32r">Freeman &#x00026; Holland 2009</xref>].</p>
        <p><bold>Allergic bronchopulmonary aspergillosis (ABPA).</bold> ABPA is a pulmonary hypersensitivity reaction to <italic toggle="yes">Aspergillus fumigatus</italic> and other molds and is most commonly seen in asthmatics and persons with cystic fibrosis. The diagnosis is based on history, elevated serum concentration of IgE, blood eosinophilia, immediate skin reactivity to <italic toggle="yes">Aspergillus fumigatus</italic> antigens, presence of precipitating serum antibodies to <italic toggle="yes">Aspergillus fumigatus</italic>, and specific imaging results, none of which are characteristic of CGD [<xref ref-type="bibr" rid="cgd.REF.greenberger.2002.685">Greenberger 2002</xref>].</p>
        <p><bold>Glucose 6-phosphate dehydrogenase (G6PD)</bold>
<bold>deficiency</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/300908">300908</ext-link>) and <bold>glutathione synthetase (GS) deficiency</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/266130">266130</ext-link>). Deficiencies in G6PD and GS affect the neutrophil respiratory burst and can increase host susceptibility to infections. Both disorders are associated with hemolytic anemia; GS deficiency is associated with 5-oxoprolinuria and intellectual disability, features not seen in CGD [<xref ref-type="bibr" rid="cgd.REF.whitin.1988.289">Whitin &#x00026; Cohen 1988</xref>, <xref ref-type="bibr" rid="cgd.REF.ristoff.2001.79">Ristoff et al 2001</xref>].</p>
        <p><bold>Crohn disease.</bold> Significant colitis leading to bowel obstruction, fistulae, and strictures can occur in patients with CGD and can be an important cause of growth retardation [<xref ref-type="bibr" rid="cgd.REF.marciano.2004.462">Marciano et al 2004</xref>]. Persons with Crohn disease also can present with weight loss, abdominal pain, diarrhea, and colitis.</p>
        <p><bold>Other.</bold> Spontaneously occurring severe or recurrent bacterial infections should always prompt consideration of immune deficiency. Persons with recurrent soft tissue infections or staphylococcal lymphadenitis should be evaluated for CGD. Presence of liver abscess or other deep tissue abscesses is concerning for CGD as well as other immunodeficiencies.</p>
        <p>Other conditions that may affect the ability of the neutrophil to generate the respiratory burst that is detected in the DHR assay include myeloperoxidase deficiency (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/254600">254600</ext-link>) [<xref ref-type="bibr" rid="cgd.REF.mauch.2007.890">Mauch et al 2007</xref>] and SAPHO (the syndrome of <italic toggle="yes">s</italic>ynovitis, <italic toggle="yes">a</italic>cne, <italic toggle="yes">p</italic>ustulosis, <italic toggle="yes">h</italic>yperostosis, and <italic toggle="yes">o</italic>steitis) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/612852">612852</ext-link>) [<xref ref-type="bibr" rid="cgd.REF.ferguson.2008.3264">Ferguson et al 2008</xref>]. In these two conditions the DHR results are abnormal, but superoxide production levels and NBT staining are normal. In addition, neither of these syndromes has overlapping infection profiles with CGD.</p>
      </sec>
      <sec id="cgd.Management">
        <title>Management</title>
        <sec id="cgd.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with chronic granulomatous disease (CGD), evaluation should include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
            <list-item>
              <p>Tests looking for evidence of infection, such as C reactive protein (CRP) and erythrocyte sedimentation rate (ESR), which are sensitive but non-specific markers of inflammation</p>
            </list-item>
            <list-item>
              <p>Complete blood count (CBC). Anemia is common either due to anemia of chronic disease or iron deficiency anemia. Poor iron absorption is common in CGD-related colitis.</p>
            </list-item>
            <list-item>
              <p>Albumin. Hypoalbuminemia is found in 70% of persons with GI involvement and in 25% of persons without GI manifestations [<xref ref-type="bibr" rid="cgd.REF.marciano.2004.462">Marciano et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p>Endoscopy and colonoscopy if signs and symptoms of colitis are present</p>
            </list-item>
            <list-item>
              <p>Imaging as it pertains to specific symptoms for diagnosis and management of infection. Because CGD can affect almost every organ system different imaging modalities can be used depending on the site affected. Because of its relative ease and sensitivity, CT scan is often used; however, ultrasound and MRI can be used instead in many instances. Positron emission tomography (PET) using fluorine-18-fluoro-2-deoxy-D-glucose (FDG) uptake can help discriminate active from resolved infection. High FDG uptake is consistent with active inflammation [<xref ref-type="bibr" rid="cgd.REF.g_ng_r.2001.341">G&#x000fc;ng&#x000f6;r et al 2001</xref>].</p>
            </list-item>
          </list>
          <sec id="cgd.Affected_Organs__Manifestations_of_C">
            <title>Affected Organs / Manifestations of CGD on Imaging</title>
            <p><bold>Lungs / pneumonia</bold> [<xref ref-type="bibr" rid="cgd.REF.godoy.2008.1570">Godoy et al 2008</xref>]</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Chest x-ray.</bold> Consolidation, reticular nodular opacities, scarring</p>
              </list-item>
              <list-item>
                <p>
                  <bold>CT</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Consolidation, ground-glass opacity, tree-in-bud opacity, centrilobular or random nodules, septal thickening, air trapping, scarring</p>
                  </list-item>
                  <list-item>
                    <p>Empyema or abscess</p>
                  </list-item>
                  <list-item>
                    <p>Mediastinal or hilar adenopathy, honeycomb lung, pleural thickening in chronic cases</p>
                  </list-item>
                  <list-item>
                    <p>Contiguous spread to chest wall, associated osteomyelitis of ribs and vertebral bodies</p>
                  </list-item>
                </list>
              </list-item>
            </list>
            <p><bold>Lymph nodes / suppurative adenitis</bold> [<xref ref-type="bibr" rid="cgd.REF.towbin.2010.657">Towbin &#x00026; Chaves 2010</xref>]</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>CT.</bold> Enhancing lymph node with central area of hypodensity and enhancing septations</p>
              </list-item>
              <list-item>
                <p>
                  <bold>US</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Swirling debris, thickened septa, and increased color Doppler flow</p>
                  </list-item>
                  <list-item>
                    <p>Calcifications if granuloma present</p>
                  </list-item>
                </list>
              </list-item>
            </list>
            <p><bold>Liver / abscess</bold> [<xref ref-type="bibr" rid="cgd.REF.garciaeulate.2006.482">Garcia-Eulate et al 2006</xref>]</p>
            <list list-type="bullet">
              <list-item>
                <p>Single to multiple small or large abscesses, sharply defined; variable enhancement but usually with small central area with poor enhancement</p>
              </list-item>
              <list-item>
                <p>Calcifications</p>
              </list-item>
            </list>
            <p><bold>Musculoskeletal / osteomyelitis</bold> [<xref ref-type="bibr" rid="cgd.REF.galluzzo.2008.745">Galluzzo et al 2008</xref>]</p>
            <list list-type="bullet">
              <list-item>
                <p>Multifocal, occurring in ribs, vertebral bodies, small bones of hands and feet</p>
              </list-item>
            </list>
            <p><bold>Genitourinary / cystitis</bold> [<xref ref-type="bibr" rid="cgd.REF.walther.1992.1314">Walther et al 1992</xref>]</p>
            <list list-type="bullet">
              <list-item>
                <p>Inflammatory pseudotumors of the bladder; on US appear as focal wall thickening</p>
              </list-item>
            </list>
            <p><bold>Gastrointestinal / obstruction and colitis</bold> [<xref ref-type="bibr" rid="cgd.REF.marciano.2004.462">Marciano et al 2004</xref>, <xref ref-type="bibr" rid="cgd.REF.laskey.2009.2368">Laskey et al 2009</xref>]</p>
            <list list-type="bullet">
              <list-item>
                <p>Obstruction</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Esophagus: strictures, diverticula, dysmotility</p>
                  </list-item>
                  <list-item>
                    <p>Thickening of bowel wall, fistulae</p>
                  </list-item>
                  <list-item>
                    <p>Upper GI: gastric outlet obstruction with gastric dilation, delayed gastric emptying, circumferential antral narrowing, thickened gastric folds</p>
                  </list-item>
                  <list-item>
                    <p>Gastric wall thickening on US, CT, or MRI</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>Colitis: Bowel wall thickening, skip lesions, luminal narrowing, fistulae, cobblestone mucosal pattern</p>
              </list-item>
            </list>
            <p><bold>Head and neck / sinusitis</bold> [<xref ref-type="bibr" rid="cgd.REF.towbin.2010.657">Towbin &#x00026; Chaves 2010</xref>]</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>MRI.</bold> Fungal sinusitis hypointense on T<sub>1</sub> and T<sub>2</sub>-weighted images, associated with bony destruction</p>
              </list-item>
              <list-item>
                <p><bold>CT.</bold> Fungal sinusitis hyperdense</p>
              </list-item>
            </list>
            <p><bold>Central nervous system / abscess</bold> [<xref ref-type="bibr" rid="cgd.REF.towbin.2010.657">Towbin &#x00026; Chaves 2010</xref>]</p>
            <list list-type="bullet">
              <list-item>
                <p>Abscesses with typical appearance on MRI with ring-enhancing lesions</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="cgd.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Serious infections</bold> may occur at any time in persons with CGD. Infections that are asymptomatic or minimally symptomatic may be identified at initial presentation. Significant rises in CRP or ESR should prompt evaluation for infection. Imaging is important in detecting and understanding the severity of infections. CT or MRI should be followed closely until resolution of infections.</p>
          <p>A definitive microbiologic diagnosis is essential to proper treatment of infections. Biopsies to identify the pathogen should be pursued prior to initiation of antimicrobial therapy unless infections are life threatening. Often obtaining an appropriate sample for diagnosis requires fine needle aspiration or percutaneous drainage of an abscess.</p>
          <p>Initially antibiotics and antifungals are often used empirically, with more selective use after the pathogen is identified. Newer azole drugs (voriconazole, posaconazole, isovuconazole) have expanded therapeutic options for fungal infections in CGD. Long courses of antimicrobials are often needed for adequate treatment. For example, those who do develop fungal infections on itraconazole prophylaxis develop them at an older age and may require longer duration of therapy.</p>
          <p>The primary prophylaxis used to prevent bacterial and fungal infections also has good activity against yeasts. However, if invasive yeast infections occur, organism-specific antimicrobials are warranted.</p>
          <p>Percutaneous drainage itself can be therapeutic, especially for liver or other intra-abdominal abscesses. Lymphadenitis and liver abscesses often require excisional surgery [<xref ref-type="bibr" rid="cgd.REF.feld.2008.1917">Feld et al 2008</xref>]. Staphylococcal liver abscesses can be effectively treated without surgery using a combination of drainage of liquid pus (if present), intravenous antimicrobials, and moderate dose corticosteroids (1 mg/kg/day tapered over 1-2 months) [<xref ref-type="bibr" rid="cgd.REF.leiding.2012.694">Leiding et al 2012</xref>].</p>
          <p><bold>Colitis.</bold> Treatment of colitis in CGD can be difficult.</p>
          <p>Corticosteroids are usually effective but have long-term complications including growth retardation, osteoporosis, and increased risk of infection. The authors&#x02019; current practice is to initiate therapy for proven colitis with prednisone 1 mg/kg/day for one to two weeks followed by a slow taper to 0.1-0.25 mg/kg/day over one to two months [<xref ref-type="bibr" rid="cgd.REF.holland.2010.3">Holland 2010</xref>].</p>
          <p>Metronidazole to reduce bowel flora, salicylic acid derivatives, 6-mercaptopurine, and mesalamine are also useful in treatment of CGD colitis.</p>
          <p>In CGD, the use of TNF-alpha inhibitors, specifically infliximab, a chimeric (mouse/human) monoclonal antibody to TNF alpha, is successful in closing fistulae but leads to increased frequency of severe infections with typical CGD pathogens or death. A report of infliximab in five persons with CGD found severe infections in all five and death in two. Of note, none of the five developed mycobacterial infections, as has been reported with use of infliximab in other conditions [<xref ref-type="bibr" rid="cgd.REF.uzel.2010.1429">Uzel et al 2010</xref>].</p>
          <p>Successful bone marrow transplantation appears to cure CGD and the related colitis [<xref ref-type="bibr" rid="cgd.REF.kang.2011.1319">Kang et al 2011</xref>].</p>
          <p><bold>Corticosteroid treatment of heightened inflammatory response.</bold> Simultaneous administration of antimicrobials and corticosteroids can help resolve the infections and extensive areas of inflammation that can occur with chronic colitis [<xref ref-type="bibr" rid="cgd.REF.marciano.2004.462">Marciano et al 2004</xref>], granulomatous cystitis [<xref ref-type="bibr" rid="cgd.REF.kontras.1971.575">Kontras et al 1971</xref>], pulmonary infections with <italic toggle="yes">Nocardia</italic> [<xref ref-type="bibr" rid="cgd.REF.freeman.2011.806">Freeman et al 2011</xref>], and staphylococcal liver abscesses [<xref ref-type="bibr" rid="cgd.REF.leiding.2012.694">Leiding et al 2012</xref>].</p>
          <p>Successful treatment of mulch pneumonitis, the exuberant inflammatory response following inhalation of mulch or other organic matter, requires the simultaneous administration of antifungals and corticosteroids [<xref ref-type="bibr" rid="cgd.REF.siddiqui.2007.673">Siddiqui et al 2007</xref>].</p>
          <p>Aggressive treatment of the syndrome of secondary <related-object link-type="booklink" source-id="gene" document-id="hlh" document-type="chapter">hemophagocytic lymphohistiocytosis</related-object> (HLH) in CGD with antimicrobials, IVIg, and steroids can lead to clinical improvement and remission [<xref ref-type="bibr" rid="cgd.REF.parekh.2011.460">Parekh et al 2011</xref>]. Because the HLH-like syndrome in CGD represents a reaction to bacterial or fungal infection, these infections must be aggressively treated if patients receive immunosuppression for HLH. Although the merit of immunosuppression in the setting of infection-triggered HLH in CGD is unclear, treatment of the infection is essential.</p>
          <p><bold>Granulocyte infusions.</bold> The value of granulocyte infusions has not been evaluated in prospective controlled trials; however, multiple case reports suggest its utility in treating serious bacterial and fungal infections [<xref ref-type="bibr" rid="cgd.REF.von_planta.1997.234">von Planta et al 1997</xref>, <xref ref-type="bibr" rid="cgd.REF.ozsahin.1998.2719">Ozsahin et al 1998</xref>, <xref ref-type="bibr" rid="cgd.REF.bielorai.2000.1025">Bielorai et al 2000</xref>, <xref ref-type="bibr" rid="cgd.REF.ikincio_ullari.2005.137">Ikincio&#x0011f;ullari et al 2005</xref>]. The principle is that a small number of normal phagocytes complement the oxidative defect in CGD phagocytes by supplying diffusible hydrogen peroxide. Transfused granulocytes have been recovered from sites of infection and appear to have normal respiratory burst activity and to traffic normally.</p>
          <p>Granulocyte infusions are generally well tolerated; however, adverse effects include fever, development of leukoagglutinins, and rarely, pulmonary leukostasis. Alloimmunization is a major concern, as many patients with histories of severe infections may also be considered for hematopoietic stem cell transplantation (HSCT) [<xref ref-type="bibr" rid="cgd.REF.heim.2011.1154">Heim et al 2011</xref>]. The possibility of CMV transmission is also a cause for caution.</p>
          <sec id="cgd.Males_with_XLinked_CGD">
            <title>Males with X-Linked CGD</title>
            <p>For males with X-linked CGD and <related-object link-type="booklink" source-id="gene" document-id="mcleod" document-type="chapter">McLeod neuroacanthocytosis syndrome</related-object> early consideration should be given to autologous blood banking (see also Establishing the Diagnosis, <xref ref-type="sec" rid="cgd.Special_Consideration_in_a_Male_with">Special Consideration in a Male with Suspected CGD and Other Medical Issues</xref>). Persons with McLeod neuroacanthocytosis syndrome do not express the erythrocyte blood group Kell antigen (i.e., they are Kell negative). Should they require transfusion of blood products, Kell-positive blood products must be avoided in order to prevent a transfusion reaction. Kell-negative blood products are rarely available.</p>
          </sec>
        </sec>
        <sec id="cgd.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p><bold>Antibacterial prophylaxis.</bold> No randomized prospective clinical trials of antibacterial prophylaxis in persons with CGD have been performed; however, several retrospective studies suggest that trimethoprim-sulfamethoxazole (TMP-SMX) is effective in preventing bacterial infections. Lifelong daily antibacterial prophylaxis with oral TMP-SMX is recommended at 5 mg/kg up to 320 mg administered in two divided doses. Note: In liquid TMP-SMX the concentration of TMP is 40 mg / 5 mL and sulfamethoxazole 200 mg / 5 mL; the therapeutic dose of TMP-SMX is determined by the TMP component.</p>
          <p>Alternatives to TMP-SMX for patients allergic to sulfonamides include trimethoprim as a single agent, dicloxacillin, cephalosporins, and fluroquinolones.</p>
          <p><bold>Antifungal prophylaxis.</bold> The use of azole antifungal drugs has markedly reduced the frequency and severity of fungal infections in CGD. Lifelong antifungal prophylaxis with itraconazole 5 mg/kg oral solution to a maximum of 200 mg once daily is recommended [<xref ref-type="bibr" rid="cgd.REF.gallin.2003.2416">Gallin et al 2003</xref>].</p>
          <p>In a randomized trial, 39 patients were assigned to receive either placebo or itraconazole (100 mg/day in patients age 5-12 years; 200 mg/day in those age &#x0003e;13 years and weight &#x0003e;50 kg); only one person receiving itraconazole had a serious fungal infection compared to seven in the placebo group [<xref ref-type="bibr" rid="cgd.REF.gallin.2003.2416">Gallin et al 2003</xref>].</p>
          <p>For those unable to tolerate itraconazole, posaconazole has been studied in the oncology setting and is likely to be effective in CGD as well [<xref ref-type="bibr" rid="cgd.REF.segal.2005.1684">Segal et al 2005</xref>].</p>
          <p>Of note, the primary prophylaxis used to prevent bacterial and fungal infections also has good activity against yeasts.</p>
          <p><bold>Immunomodulatory therapy.</bold> Interferon gamma (IFN-gamma) has become part of the prophylactic regimen in most centers in the United States; however, opinions differ on its use as primary prophylaxis and in the treatment of acute infections. The exact mechanism of IFN-gamma in CGD is not known, adding to the debate over its utility.</p>
          <p>An international multicenter randomized prospective placebo-controlled trial showed a decrease in the rate of serious infections in the group receiving IFN-gamma (22%) versus placebo (46%) after a follow-up period of 8.9 months. This improvement was independent of age, CGD genotype, or concomitant use of other prophylactic antibiotics. Three prospective Phase IV trials showed decreased rates of infections ranging from 0.13 to 0.4 per patient year. However, one prospective study comparing treatment with TMP-SMX and itraconazole alone versus addition of IFN-gamma showed no difference in the rates of infection [<xref ref-type="bibr" rid="cgd.REF.martire.2008.155">Martire et al 2008</xref>].</p>
          <p>Some practitioners use IFN-gamma only in the setting of acute infection, rather than as primary prophylaxis. The data for this are anecdotal and unimpressive. The authors typically discontinue IFN-gamma during acute infection, as its utility is unclear and the exacerbation of malaise and fever can confuse the clinical picture and alter decision making [<xref ref-type="bibr" rid="cgd.REF.holland.2010.3">Holland 2010</xref>].</p>
          <p>Administration by injection, cost, and lack of familiarity with cytokine therapy all affect the use of IFN-gamma in CGD. The authors use IFN-gamma in addition to antimicrobials as prophylaxis [<xref ref-type="bibr" rid="cgd.REF.holland.2010.3">Holland 2010</xref>]. Dosing is based on body surface area (BSA). For BSA &#x0003e;0.5/m<sup>2</sup> the dose is 50 &#x003bc;g/m<sup>2</sup> subcutaneously 3x/week; for BSA &#x02264;0.5/m<sup>2</sup> the dose is 1.5 &#x003bc;g/kg subcutaneously 3x/week. Fever, myalgias, and malaise are the most common side effects but can be alleviated with concurrent administration of acetaminophen.</p>
          <p><bold>Hematopoietic stem cell transplantation (HSCT).</bold> Allogeneic HSCT is the only known cure for CGD. Historically, HSCT has been associated with high morbidity and mortality and thus reluctantly offered. However, the use of non-myeloablative conditioning regimens has greatly decreased the risk of regimen-related toxicity as well as allowing for transplantation in the setting of active infection; recent reports place transplant survival at greater than 90% [<xref ref-type="bibr" rid="cgd.REF.g_ng_r.2014.436">G&#x000fc;ng&#x000f6;r et al 2014</xref>] with roughly equal survival among patients with matched related, matched unrelated, and umbilical cord blood donors.</p>
          <p>The issue of which individuals with CGD should undergo HSCT remains complex. While transplant-related mortality rates have fallen dramatically and successful cure has risen, issues of long-term risk, sterility, graft-versus-host disease, donor matching, expense, center experience, availability, and insurance coverage all strongly influence family and physician choices regarding transplantation. Levels of residual superoxide production have correlated well with overall survival [<xref ref-type="bibr" rid="cgd.REF.kuhns.2010.2600">Kuhns et al 2010</xref>]; that is, individuals with very low superoxide production had worse long-term survival than those with higher levels of residual superoxide production, suggesting that this latter group could benefit more from transplantation. However, even within this group some patients do relatively well for long periods.</p>
          <p>Patients with CGD may experience behavioral, emotional, and learning difficulties as a consequence of chronic disease, recurrent hospitalization, and limitations of activity. Older children and adolescents are especially likely to be non-compliant with respect to prophylaxis and risk avoidance, increasing their risk for CGD-related complications. The inflammatory bowel disease present in up to 50% of persons with X-linked CGD may result in discomfort and growth impairment, and may require colostomy or colectomy. Overall quality of life is reduced in children with CGD, whereas patients with CGD who have undergone transplant report quality of life comparable to healthy children [<xref ref-type="bibr" rid="cgd.REF.cole.2013.8">Cole et al 2013</xref>]. Thus, with improved outcomes HSCT presents an increasingly reasonable alternative and the possibility of a normal life.</p>
          <p>As HSCT becomes safer, more reliable and more available it will likely be an early and initial choice for the management of CGD. Currently, many centers offer HSCT after the first life-threatening infection, but with advances in the technique, the availability of donors, especially for minority populations, and the availability of experienced centers, that equation and timing may change. Even without HSCT the majority of persons with CGD will live into adulthood. There is currently very little difference in overall survival over the first decades of life between medical and transplant management. However, the significant mortality in medical management begins to accrue after age 20 [<xref ref-type="bibr" rid="cgd.REF.kuhns.2010.2600">Kuhns et al 2010</xref>]. Aggressive prophylaxis and infection management increase the likelihood of doing well.</p>
          <p>The European Bone Marrow Transplantation (EBMT) Working Group 2011 statement [<xref ref-type="bibr" rid="cgd.REF24">EBMT Working Group 2011</xref>] recommends allogeneic bone marrow transplantation for CGD in the case of unavailability of reliable specialist medical care, non-compliance with long-term antibiotic/antifungal prophylaxis, one or more life-threatening infections, severe granulomatous disease with progressive organ dysfunction (e.g., lung restriction), steroid-dependent granulomatous disease (e.g., colitis), or ongoing therapy-refractory infection (e.g., aspergillosis).</p>
        </sec>
        <sec id="cgd.Surveillance">
          <title>Surveillance</title>
          <p>Regular follow-up visits can aid in early detection and treatment of asymptomatic or minimally symptomatic infections and non-infectious complications such as colitis, pulmonary granulomas, and pulmonary fibrosis [<xref ref-type="bibr" rid="cgd.REF.roesler.2005.513">Roesler et al 2005</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Laboratory examinations include CBC, chemistries, CRP, and ESR.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Significant rises in CRP or ESR should prompt evaluation for infection.</p>
                </list-item>
                <list-item>
                  <p>Presence of microcytic anemia and hypoalbuminemia may indicate development of colitis.</p>
                </list-item>
                <list-item>
                  <p>Monitor liver chemistries for transaminase and alkaline phosphatase elevation, especially drug-related hepatotoxicity.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Although imaging is also important in detection of infectious and non-infectious manifestations, no specific guidelines address the intervals at which imaging should be used. CT or MRI should be followed closely to monitor progression of disease or until resolution of infections.</p>
            </list-item>
          </list>
          <p>Frequent follow-up visits also provide the treating clinician opportunities to encourage compliance with prophylaxis and educate the patient and family about the disease.</p>
        </sec>
        <sec id="cgd.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p><bold>Exposures.</bold> Activities that expose the affected person to decayed organic matter (e.g., mulching, gardening, leaf raking, house demolition) are to be avoided as inhalation of fungal spores can result in fulminant pneumonitis leading to hypoxia and respiratory failure [<xref ref-type="bibr" rid="cgd.REF.siddiqui.2007.673">Siddiqui et al 2007</xref>]. Therefore, the following should be avoided:</p>
          <list list-type="bullet">
            <list-item>
              <p>Exposure to mulch</p>
            </list-item>
            <list-item>
              <p>Potting of plants or gardening</p>
            </list-item>
            <list-item>
              <p>Raking leaves or mowing lawns</p>
            </list-item>
            <list-item>
              <p>Swimming in stagnant water, brackish water, or ponds</p>
            </list-item>
          </list>
          <p><bold>BCG vaccination</bold> should be avoided (live viral vaccines are likely safe).</p>
          <p><bold>Transfusion considerations.</bold> Persons with CGD and <related-object link-type="booklink" source-id="gene" document-id="mcleod" document-type="chapter">McLeod neuroacanthocytosis syndrome</related-object> lack red blood cell Kell antigens and thus should not receive blood transfusions that are Kell antigen positive.</p>
        </sec>
        <sec id="cgd.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate apparently asymptomatic at-risk relatives in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures.</p>
          <p>Evaluations can include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Molecular genetic testing if the pathogenic variant(s) in the family are known</p>
            </list-item>
            <list-item>
              <p>Routine DHR testing of peripheral blood, which will detect the CGD disease state (except for p40phox deficiency) if the pathogenic variant(s) in the family are not known</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="cgd.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="cgd.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>The major concern during the pregnancy of a woman known to have CGD is continued use of prophylactic antimicrobials.</p>
          <list list-type="bullet">
            <list-item>
              <p>Trimethoprim, a folic acid antagonist, is usually avoided in pregnancy</p>
            </list-item>
            <list-item>
              <p>Sulfamethoxazole is not known to increase the risk of birth defects in humans; however, it is typically administered in conjunction with trimethoprim for prophylaxis in affected non-pregnant women.</p>
            </list-item>
            <list-item>
              <p>Data regarding teratogenicity of itraconazole are limited. Although case reports of birth defects in infants born to women taking itraconazole during pregnancy have been published, this observation is not supported by larger case series. Given the lack of adequate data on the use of itraconazole during pregnancy, some practitioners suggest that it should be avoided during pregnancy until such data become available.</p>
            </list-item>
          </list>
          <p>The authors&#x02019; practice for women with CGD who are or are planning to become pregnant is to use antibacterial prophylaxis (e.g., penicillin- or cephalosporin-based therapies) for which more data on safety during pregnancy exist [Author, personal communication]. Although no antifungal prophylactic medications known to be completely safe during pregnancy are currently available, the risks and benefits of antifungal treatment must be weighed case by case. Interferon gamma is held during pregnancy and restarted after breastfeeding has ceased.</p>
        </sec>
        <sec id="cgd.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p><bold>Gene therapy.</bold> CGD is an attractive target for gene therapy: the disorder results from a single gene defect, neutrophil superoxide production can be reconstituted in vitro, and correction of neutrophil superoxide production need not be complete to provide complete protection, as exemplified by X-linked carriers. Although initially unsuccessful, more recent gene therapy efforts have been encouraging.</p>
          <p>Early trials using retrovirus-based therapy were complicated by loss of engraftment. Most forms of CGD gene therapy seek to introduce a retroviral vector containing normal <italic toggle="yes">CYBB</italic> into mobilized CD34 stem cells. <xref ref-type="bibr" rid="cgd.REF.ott.2006.401">Ott et al [2006]</xref> reported successful early levels of gene-corrected oxidase-producing circulating neutrophils in two adults with X-linked CGD. While there was initial clinical benefit to both patients, over time gene silencing with loss of oxidase activity and myelodysplasia developed. <xref ref-type="bibr" rid="cgd.REF.kang.2010.783">Kang et al [2010]</xref> reported three individuals with X-linked CGD who underwent gene therapy: two had low-level correction of neutrophil superoxide production. One had resolution of infection with 1.1% of neutrophils regaining gp91<italic toggle="yes"><sup>phox</sup></italic> expression. The lack of an intrinsic survival advantage for gene-corrected CGD cells further complicated low rates of correction. All three individuals lost corrected gene expression over the course of several months.</p>
          <p>Hematopoietic gene therapy in general and in CGD in particular has been complicated by the development of hematologic malignancies [<xref ref-type="bibr" rid="cgd.REF.ott.2006.401">Ott et al 2006</xref>, <xref ref-type="bibr" rid="cgd.REF.stein.2010.198">Stein et al 2010</xref>]. Two adults who were treated with retrovirus-based therapy developed monosomy 7 secondary to retroviral insertional activation of transcription of the oncogene <italic toggle="yes">MECOM</italic> (<italic toggle="yes">MDS</italic> and <italic toggle="yes">EVI1</italic> complex locus).</p>
          <p>Promising results with the use of lentiviral vectors in a murine X-linked CGD model have been obtained [<xref ref-type="bibr" rid="cgd.REF.chiriaco.2014.1472">Chiriaco et al 2014</xref>]. Recently an international study using a lentiviral vector encoding a chimeric myeloid promoter in patients with X-linked CGD has opened. As is true for many forms of hematopoietic stem cell gene therapy, the treatment of CGD will require some chemotherapeutic bone marrow conditioning to facilitate long-term corrected cell engraftment and persistence.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ClinicalTrials.gov">ClinicalTrials.gov</ext-link> for information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="cgd.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cgd.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Granulomatous disease associated with a pathogenic variant in <italic toggle="yes">CYBB</italic> is inherited in an X-linked manner.</p>
          <p>Chronic granulomatous disease associated with biallelic pathogenic variants in <italic toggle="yes">CYBA</italic>, <italic toggle="yes">NCF1</italic>, <italic toggle="yes">NCF2</italic>, or <italic toggle="yes">NCF4</italic> is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="cgd.Risk_to_Family_Members__XLinked_Inhe">
          <title>Risk to Family Members &#x02014; X-Linked Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will not have the disease nor will he be a carrier of the <italic toggle="yes">CYBB</italic> pathogenic variant; therefore, he does not require further evaluation/testing.</p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected individual, the mother of an affected male is an obligate heterozygote (carrier). Note: If a woman has more than one affected child and no other affected relatives and if the pathogenic variant identified in her affected son cannot be detected in her leukocyte DNA, she has germline mosaicism.</p>
            </list-item>
            <list-item>
              <p>If a male is the only affected family member (i.e., a simplex case), the mother may be heterozygous for a <italic toggle="yes">CYBB</italic> pathogenic variant, the affected male may have a <italic toggle="yes">de novo</italic> pathogenic variant (and, thus, the mother is not heterozygous for a <italic toggle="yes">CYBB</italic> pathogenic variant), or the mother may have germline mosaicism.</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">De novo</italic>
<italic toggle="yes">CYBB</italic> pathogenic variants have been reported [<xref ref-type="bibr" rid="cgd.REF.gono.2008.1053">Gono et al 2008</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the carrier status of the mother of the proband: if she has a <italic toggle="yes">CYBB</italic> pathogenic variant, the chance of transmitting it in each pregnancy is 50%.</p>
            </list-item>
            <list-item>
              <p>Males who inherit the pathogenic variant will be affected</p>
            </list-item>
            <list-item>
              <p>Females who inherit the pathogenic variant will be heterozygotes. (See <xref ref-type="sec" rid="cgd.Carriers_of_XLinked_CGD">Carriers of X-Linked CGD</xref>.)</p>
              <list list-type="bullet">
                <list-item>
                  <p>Females heterozygous for a <italic toggle="yes">CYBB</italic> pathogenic variant are typically unaffected as the amount of gp91<sup>phox</sup> produced by their second (normal) <italic toggle="yes">CYBB</italic> allele allows adequate superoxide production and protection from CGD-related infections. Some heterozygous females are at risk for inflammatory diseases such as discoid lupus.</p>
                </list-item>
                <list-item>
                  <p>However, some heterozygous women develop CGD-related infections because they express primarily the <italic toggle="yes">CYBB</italic> disease-causing allele as the result of skewed (non-random) X-chromosome inactivation. This condition (significantly skewed X-chromosome inactivation, typically &#x0003c;20% normal allele expression) can develop over time in a heterozygous female; thus the X-inactivation level at one point in time does not necessarily predict the values at a later point.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If the proband represents a simplex case (i.e., a single occurrence in a family) and if the <italic toggle="yes">CYBB</italic> pathogenic variant identified in her affected son cannot be detected in the leukocyte DNA of the mother, the risk to sibs is still greater than that of the general population because of the possibility of maternal germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a male proband.</bold> Affected males transmit the <italic toggle="yes">CYBB</italic> pathogenic variant to:</p>
          <list list-type="bullet">
            <list-item>
              <p>All of their daughters, who will be heterozygotes (see <xref ref-type="sec" rid="cgd.Carriers_of_XLinked_CGD">Carriers of X-Linked CGD</xref>);</p>
            </list-item>
            <list-item>
              <p>None of their sons.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> The proband&#x02019;s mother and maternal aunts may be at risk of being heterozygotes (carriers) for the <italic toggle="yes">CYBB</italic> pathogenic variant and the aunts&#x02019; offspring are at risk of being heterozygous and/or affected as well.</p>
          <p>Note: Dihydrorhodamine (DHR) testing or molecular genetic testing may help determine the family member in whom a <italic toggle="yes">de novo</italic> pathogenic variant arose, information that could help determine genetic risk status of the extended family.</p>
        </sec>
        <sec id="cgd.Heterozygote_Carrier_Detection">
          <title>Heterozygote (Carrier) Detection</title>
          <p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <italic toggle="yes">CYBB</italic> pathogenic variant has been identified in the proband.</p>
          <p>Women who are carriers of X-linked CGD have circulating populations of oxidase-positive and oxidase-negative phagocytes, which can be resolved by DHR testing if the family-specific pathogenic variant has not been identified or if molecular genetic testing of <italic toggle="yes">CYBB</italic> is not available.</p>
          <p>Note: Females who are heterozygous (carriers) for X-linked CGD are typically unaffected (see <xref ref-type="sec" rid="cgd.Carriers_of_XLinked_CGD">Carriers of X-Linked CGD</xref>).</p>
        </sec>
        <sec id="cgd.Risk_to_Family_Members__Autosomal_Re">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are typically heterozygous for a <italic toggle="yes">CYBA</italic>, <italic toggle="yes">NCF1</italic>, <italic toggle="yes">NCF2</italic>, or <italic toggle="yes">NCF4</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are usually asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an individual with AR-CGD has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with AR-CGD are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">CYBA</italic>, <italic toggle="yes">NCF1</italic>, <italic toggle="yes">NCF2,</italic> or <italic toggle="yes">NCF4</italic>.</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">CYBA</italic>, <italic toggle="yes">NCF1</italic>, <italic toggle="yes">NCF2,</italic> or <italic toggle="yes">NCF4</italic> pathogenic variant assuming that the AR-CGD pathogenic variant is germline in the parent.</p>
          <p>Note: Because <italic toggle="yes">NCF1</italic> is flanked by two pseudogenes, <italic toggle="yes">de novo</italic> pathogenic variants can result from gene conversion during meiosis. Such pathogenic variants occur with a low but finite frequency in the general population [<xref ref-type="bibr" rid="cgd.REF.brunson.2010.13">Brunson et al 2010</xref>] and may explain the rare occurrence of pseudodominant inheritance of CGD caused by <italic toggle="yes">NCF1</italic> pathogenic variants.</p>
        </sec>
        <sec id="cgd.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for relatives at risk for AR-CGD requires prior identification of the <italic toggle="yes">CYBA</italic>, <italic toggle="yes">NCF1</italic>, <italic toggle="yes">NCF2,</italic> or <italic toggle="yes">NCF4</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="cgd.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="cgd.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on testing at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="cgd.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p><bold>Molecular genetic testing.</bold> If the <italic toggle="yes">CYBB</italic>, <italic toggle="yes">CYBA</italic>, <italic toggle="yes">NCF1</italic>, <italic toggle="yes">NCF2,</italic> or <italic toggle="yes">NCF4</italic> pathogenic variant(s) have been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this gene or custom prenatal testing.</p>
          <p><bold>Percutaneous umbilical blood sampling (PUBS)<italic toggle="yes">.</italic></bold> If the pathogenic variants are not known, prenatal diagnosis can be made by analysis of neutrophil oxidase production from umbilical vein samples obtained via PUBS. However, this procedure is performed well into the second trimester and is associated with substantial risk [<xref ref-type="bibr" rid="cgd.REF.newburger.1979.178">Newburger et al 1979</xref>, <xref ref-type="bibr" rid="cgd.REF.ayatollahi.2006.1334">Ayatollahi &#x00026; Geramizadeh 2006</xref>].</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the <italic toggle="yes">CYBB</italic>, <italic toggle="yes">CYBA</italic>, <italic toggle="yes">NCF1</italic>, <italic toggle="yes">NCF2,</italic> or <italic toggle="yes">NCF4</italic> pathogenic variant(s) have been identified.</p>
          <p>PGD has also been used to identify female HLA-matched sibs of a male with X-linked CGD. After successful in vitro fertilization (IVF), embryo transfer, and pregnancy outcome, the female sib served as a hematopoietic stem cell donor for the affected child [<xref ref-type="bibr" rid="cgd.REF.reichenbach.2008.e778">Reichenbach et al 2008</xref>].</p>
        </sec>
      </sec>
      <sec id="cgd.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cgd.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="cgd.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Chronic granulomatous disease is a single phenotype caused by mutation of one of five genes that encode proteins of NADPH oxidase. The genes and the official names of their protein products are listed in <related-object source-id="gene" document-id="cgd" object-id="cgd.molgen.TA">Table A</related-object>. However, the protein components are generally known by the names of gp91<sup>phox</sup> (encoded by <italic toggle="yes">CYBB</italic>) and p22<sup>phox</sup> (<italic toggle="yes">CYBA</italic>), which are membrane bound, and p47<sup>phox</sup> (<italic toggle="yes">NCF1)</italic>, p67<sup>phox</sup> (<italic toggle="yes">NCF2</italic>), and p40<sup>phox</sup> (<italic toggle="yes">NCF4</italic>), which are cytoplasmic.</p>
          <sec id="cgd.CYBA">
            <title>
              <italic toggle="yes">CYBA</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CYBA</italic> comprises six exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cgd" object-id="cgd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold>
<xref ref-type="bibr" rid="cgd.REF.roos.2010a.291">Roos et al [2010a]</xref> reported 55 different pathogenic variants in 96 individuals from 87 families. The majority were missense variants (34.6%) followed by deletions (29.1%), splice site variants (20.0%), nonsense variants (12.7%), and insertions (3.6%). Compound heterozygotes have been reported [<xref ref-type="bibr" rid="cgd.REF.kuhns.2010.2600">Kuhns et al 2010</xref>].</p>
            <table-wrap id="cgd.T.cyba_variants_discussed_in_this_ge" orientation="portrait" position="anchor">
              <label>Table 3. </label>
              <caption>
                <p><italic toggle="yes">CYBA</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cgd.T.cyba_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_cgd.T.cyba_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_cgd.T.cyba_variants_discussed_in_this_ge_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cgd.T.cyba_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.467C&#x0003e;A</td>
                    <td headers="hd_h_cgd.T.cyba_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro156Gln</td>
                    <td headers="hd_h_cgd.T.cyba_variants_discussed_in_this_ge_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000101.3">NM_000101.3</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> Cytochrome b comprises a light chain (alpha subunit) and a heavy chain (beta subunit). <italic toggle="yes">CYBA</italic> encodes the alpha subunit which has been proposed as a primary component of the microbicidal oxidase system of phagocytes (provided by <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/refseq/rsg">RefSeqGene</ext-link>, December 2011).</p>
            <p>The cytochrome b-245 light chain (p22<italic toggle="yes"><sup>phox</sup></italic>) and cytochrome b-245 heavy chain (gp91<italic toggle="yes"><sup>phox</sup></italic>; encoded by <italic toggle="yes">CYBB</italic>) require each other for expression in the phagocyte membrane.</p>
            <p><bold>Abnormal gene product.</bold> In all pathogenic variant-positive cases in which p22<italic toggle="yes"><sup>phox</sup></italic> expression was evaluated, protein expression was absent except in one missense variant, in which proline was replaced with glutamine at position 156 [<xref ref-type="bibr" rid="cgd.REF.roos.2010a.291">Roos et al 2010a</xref>].</p>
          </sec>
          <sec id="cgd.CYBB">
            <title>
              <italic toggle="yes">CYBB</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">CYBB</italic> , previously known as <italic toggle="yes">NOX2,</italic> comprises 13 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cgd" object-id="cgd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> In a recent update of hematologically important pathogenic variants causing X-linked CGD, <xref ref-type="bibr" rid="cgd.REF.roos.2010b.246">Roos et al [2010b]</xref> reported a total of 681 pathogenic variants, the majority of which were nonsense variants (29.8%) followed by deletions (22.2%), splice site variants (19.5%), missense variants (19.4%), insertions (1.5%), deletions/insertions (1.5%), and promoter variants (0.6%).</p>
            <p>Two <italic toggle="yes">CYBB</italic> missense variants with an exclusive association to BCG mycobacterial disease susceptibility have been described. These pathogenic variants preserved superoxide production in neutrophils and monocytes but impaired superoxide production in macrophages and B cells (see <xref ref-type="sec" rid="cgd.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</xref>).</p>
            <table-wrap id="cgd.T.cybb_variants_discussed_in_this_ge" orientation="portrait" position="anchor">
              <label>Table 4. </label>
              <caption>
                <p><italic toggle="yes">CYBB</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cgd.T.cybb_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_cgd.T.cybb_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_h_cgd.T.cybb_variants_discussed_in_this_ge_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cgd.T.cybb_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.532A&#x0003e;C</td>
                    <td headers="hd_h_cgd.T.cybb_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr178Pro</td>
                    <td headers="hd_h_cgd.T.cybb_variants_discussed_in_this_ge_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000397.3">NM_000397.3</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cgd.T.cybb_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.692A&#x0003e;C</td>
                    <td headers="hd_h_cgd.T.cybb_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln231Pro</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> Cytochrome b comprises a light chain (alpha subunit) and a heavy chain (beta subunit). <italic toggle="yes">CYBB</italic> encodes the cytochrome b-245 beta subunit. The cytochrome b-245 light chain (p22<sup>phox</sup>; encoded by <italic toggle="yes">CYBA</italic>) and cytochrome b-245 heavy chain (gp91<sup>phox</sup>) require each other for expression in the phagocyte membrane.</p>
            <p><bold>Abnormal gene product.</bold> In all affected males with a <italic toggle="yes">CYBB</italic> pathogenic variant in whom gp91<italic toggle="yes"><sup>phox</sup></italic> expression was evaluated, protein expression was absent or decreased [<xref ref-type="bibr" rid="cgd.REF.roos.2010b.246">Roos et al 2010b</xref>].</p>
          </sec>
          <sec id="cgd.NCF1">
            <title>
              <italic toggle="yes">NCF1</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">NCF1</italic> comprises 11 exons. The presence of two pseudogenes, <italic toggle="yes">NCF1B</italic> and <italic toggle="yes">NCF1C,</italic> which are more than 98% homologous to the functional <italic toggle="yes">NCF1,</italic> has complicated the identification of other pathogenic variants in <italic toggle="yes">NCF1</italic>. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cgd" object-id="cgd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Recombination events between <italic toggle="yes">NCF1</italic> and flanking pseudogenes with the deletion c.75_76delGT result in the incorporation of the deletion into the <italic toggle="yes">NCF1</italic> allele [<xref ref-type="bibr" rid="cgd.REF.g_rlach.1997.1907">G&#x000f6;rlach et al 1997</xref>]. The GT dinucleotide deletion c.75_76delGT occurs at a GTGT tandem repeat and is the most common CGD-causing allele in the population, with a carrier frequency of 1:250. The c.75_76delGT deletion is at the beginning of exon 2 and results in a frameshift and premature stop codon. <xref ref-type="bibr" rid="cgd.REF.roos.2010a.291">Roos et al [2010a]</xref> reported that of about 350 affected individuals investigated worldwide, 297 were homozygous for the <xref ref-type="table" rid="cgd.T.ncf1_pathogenic_variants_discussed">c.75_76delGT</xref> pathogenic variant. Of the exceptions, 20 were compound heterozygous for the c.75_76delGT pathogenic variant and a second pathogenic variant, while 22 had pathogenic variants other than c.75_76delGT.</p>
            <table-wrap id="cgd.T.ncf1_pathogenic_variants_discussed" orientation="portrait" position="anchor">
              <label>Table 5. </label>
              <caption>
                <p><italic toggle="yes">NCF1</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cgd.T.ncf1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_cgd.T.ncf1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_cgd.T.ncf1_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cgd.T.ncf1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.75_76delGT (&#x00394;GT)</td>
                    <td headers="hd_h_cgd.T.ncf1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.(Tyr26HisfsTer26)</td>
                    <td headers="hd_h_cgd.T.ncf1_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000265.4">NM_000265.4</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000256.3">NP_000256.3</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The protein p47<italic toggle="yes"><sup>phox</sup></italic> encoded by <italic toggle="yes">NCF1</italic> is a 47-kd cytosolic subunit of the multi-protein NADPH oxidase complex found in neutrophils.</p>
            <p><bold>Abnormal gene product.</bold> In all affected individuals with <italic toggle="yes">NCF1</italic> pathogenic variants where p47<sup>phox</sup> expression was evaluated, protein expression was absent [<xref ref-type="bibr" rid="cgd.REF.roos.2010a.291">Roos et al 2010a</xref>].</p>
          </sec>
          <sec id="cgd.NCF2">
            <title>
              <italic toggle="yes">NCF2</italic>
            </title>
            <p><bold>Gene structure.</bold> The <italic toggle="yes">NCF2</italic> transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000433.3">NM_000433.3</ext-link> comprises 15 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cgd" object-id="cgd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign variants.</bold> Alternative splicing of <italic toggle="yes">NCF2</italic> results in multiple transcript variants encoding different isoforms.</p>
            <p><bold>Pathogenic variants.</bold> A total of 54 different pathogenic variants in 95 individuals from 83 families have been described [<xref ref-type="bibr" rid="cgd.REF.roos.2010a.291">Roos et al 2010a</xref>]. The majority were missense variants (31.5%) followed by deletions (25.9%), splice site variants (20.4%), nonsense variants (14.8%), and insertions (7.4%).</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">NCF2</italic> encodes neutrophil cytosolic factor 2, the 67-kd cytosolic subunit of the multi-protein NADPH oxidase complex found in neutrophils. The protein is often designated as p67<italic toggle="yes"><sup>phox</sup></italic>.</p>
            <p><bold>Abnormal gene product.</bold> In all affected individuals with <italic toggle="yes">NCF2</italic> pathogenic variants where p67<sup>phox</sup> expression was evaluated, protein expression was absent or decreased except for one deletion of lysine at amino acid 196 and one deletion of lysine at amino acid 58 [<xref ref-type="bibr" rid="cgd.REF.roos.2010a.291">Roos et al 2010a</xref>].</p>
          </sec>
          <sec id="cgd.NCF4">
            <title>
              <italic toggle="yes">NCF4</italic>
            </title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">NCF4</italic> transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_013416.3">NM_013416.3</ext-link> is the longest and comprises nine exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cgd" object-id="cgd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign variants.</bold> Alternatively spliced transcript variants encoding distinct isoforms have been observed.</p>
            <p><bold>Pathogenic variants.</bold> Pathogenic variants in <italic toggle="yes">NCF4</italic> have been reported in a single case [<xref ref-type="bibr" rid="cgd.REF.matute.2009.3309">Matute et al 2009</xref>]. A c.143_152dup10 duplication led to premature truncation of the protein. A missense variant (p.Arg105Gln) on the other allele suggested production of a nonfunctional p40<sup>phox</sup> protein.</p>
            <table-wrap id="cgd.T.ncf4_variants_discussed_in_this_ge" orientation="portrait" position="anchor">
              <label>Table 6. </label>
              <caption>
                <p><italic toggle="yes">NCF4</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cgd.T.ncf4_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_cgd.T.ncf4_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_cgd.T.ncf4_variants_discussed_in_this_ge_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cgd.T.ncf4_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.143_152dup10</td>
                    <td headers="hd_h_cgd.T.ncf4_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.(Lys52ArgfsTer79)</td>
                    <td headers="hd_h_cgd.T.ncf4_variants_discussed_in_this_ge_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_013416.3">NM_013416.3</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cgd.T.ncf4_variants_discussed_in_this_ge_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.314G&#x0003e;A</td>
                    <td headers="hd_h_cgd.T.ncf4_variants_discussed_in_this_ge_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg105Gln</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> The protein encoded by <italic toggle="yes">NCF4</italic> is a cytosolic regulatory component of the superoxide-producing phagocyte NADPH-oxidase, a multicomponent enzyme system important for host defense. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_013416.3">NM_013416.3</ext-link> encodes the longest isoform <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_038202.2">NP_038202.2</ext-link>, which has 348 amino acid residues.</p>
            <p><bold>Abnormal gene product.</bold> In the one reported affected individual <italic toggle="yes">NCF4</italic> pathogenic variants predicted a loss of functional protein.</p>
          </sec>
        </sec>
      </sec>
      <sec id="cgd.References">
        <title>References</title>
        <sec id="cgd.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="cgd.Literature_Cited.reflist0">
            <ref id="cgd.REF.aguilera.2009.965">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aguilera</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajaram</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fangusaro</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katz</surname>
                    <given-names>BZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shulman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldman</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Glioblastoma multiforme in a patient with chronic granulomatous disease treated with subtotal resection, radiation, and thalidomide: case report of a long-term survivor.</article-title>
                <source>J Pediatr Hematol Oncol.</source>
                <volume>31</volume>
                <fpage>965</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19887959</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.ahlin.1995.1386">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ahlin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Boer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leusen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sundin</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabbani</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmblad</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elinder</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden.</article-title>
                <source>Acta Paediatr.</source>
                <year>1995</year>
                <volume>84</volume>
                <fpage>1386</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">8645957</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.alzadjali.2015.185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Zadjali</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Tamemi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elnour</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>AlKindi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lapoumeroulie</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Maamari</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pathare</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dennison</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krishnamoorthy</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and molecular findings of chronic granulomatous disease in Oman:family studies.</article-title>
                <source>Clin Genet.</source>
                <year>2015</year>
                <volume>87</volume>
                <fpage>185</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24446915</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.andersoncohen.2003.308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anderson-Cohen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhns</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleisher</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roesler</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non-familial, extremely skewed X chromosome inactivation.</article-title>
                <source>Clin Immunol.</source>
                <volume>109</volume>
                <fpage>308</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">14697745</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.ayatollahi.2006.1334">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ayatollahi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geramizadeh</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Carrier screening and prenatal detection of chronic granulomatous disease in Iran.</article-title>
                <source>Saudi Med J.</source>
                <year>2006</year>
                <volume>27</volume>
                <fpage>1334</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16951769</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.baba.2014.452">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baba</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ailal</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El Hafidi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jabot-Hanin</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benajiba</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aadam</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deswarte</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeddane</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aglaguel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El Maataoui</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tissent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahraoui</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Najib</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Barricarte</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abel</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habti</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saile</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casanova</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bustamante</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alj</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousfiha</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <article-title>Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds.</article-title>
                <source>J Clin Immunol.</source>
                <year>2014</year>
                <volume>34</volume>
                <fpage>452</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">24596025</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.badalzadeh.2012.340">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Badalzadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fattahi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fazlollahi</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tajik</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bemanian</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Behmanesh</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Movahedi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houshmand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pourpak</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <article-title>Molecular analysis of four cases of chronic granulomatous disease caused by defects in NCF-2: the gene encoding the p67-phox.</article-title>
                <source>Iran J Allergy Asthma Immunol.</source>
                <year>2012</year>
                <volume>11</volume>
                <fpage>340</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">23264412</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.baehner.1967.835">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baehner</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nathan</surname>
                    <given-names>DG</given-names>
                  </name>
                </person-group>
                <article-title>Leukocyte oxidase: defective activity in chronic granulomatous disease.</article-title>
                <source>Science.</source>
                <year>1967</year>
                <volume>155</volume>
                <fpage>835</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">6018195</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.beaut_.2011.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beaut&#x000e9;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obenga</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Mignot</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahlaoui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bougnoux</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mouy</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gougerot-Pocidalo</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barlogis</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suarez</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanternier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermine</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lecuit</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanche</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lortholary</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <article-title>Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France.</article-title>
                <source>Pediatr Infect Dis J.</source>
                <year>2011</year>
                <volume>30</volume>
                <fpage>57</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">20700078</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.bender.2009.529">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bender</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rand</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ampofo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavia</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schober</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tebo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Augustine</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pryor</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wittwer</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>HR</given-names>
                  </name>
                </person-group>
                <article-title>Family clusters of variant X-linked chronic granulomatous disease.</article-title>
                <source>Pediatr Infect Dis J.</source>
                <year>2009</year>
                <volume>28</volume>
                <fpage>529</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">19483518</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.bielorai.2000.1025">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bielorai</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolach</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplinisky</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weintraub</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amariglio</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paswell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rechavi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.</article-title>
                <source>Bone Marrow Transplant.</source>
                <year>2000</year>
                <volume>26</volume>
                <fpage>1025</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11100285</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.blumental.2011.e159">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blumental</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mouy</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahlaoui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bougnoux</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Debre</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beaut&#x000e9;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lortholary</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanche</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey.</article-title>
                <source>Clin Infect Dis.</source>
                <year>2011</year>
                <volume>53</volume>
                <fpage>e159</fpage>
                <lpage>69</lpage>
                <pub-id pub-id-type="pmid">22080130</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.bridges.1959.387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bridges</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berendes</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Good</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <article-title>A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome.</article-title>
                <source>AMA J Dis Child.</source>
                <year>1959</year>
                <volume>97</volume>
                <fpage>387</fpage>
                <lpage>408</lpage>
                <pub-id pub-id-type="pmid">13636694</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.brunson.2010.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brunson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chambers</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>Q.</given-names>
                  </name>
                </person-group>
                <article-title>A copy number variation in human NCF1 and its pseudogenes.</article-title>
                <source>BMC Genet.</source>
                <year>2010</year>
                <volume>11</volume>
                <fpage>13</fpage>
                <pub-id pub-id-type="pmid">20178640</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.bustamante.2011.213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bustamante</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arias</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogt</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galicia</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prando</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchal</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapgier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Beaucoudrey</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feinberg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valinetz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janniere</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Besse</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boland</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brisseau</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanche</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lortholary</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fieschi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emile</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boisson-Dupuis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Muhsen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woda</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newburger</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Condino-Neto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinauer</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease.</article-title>
                <source>Nat Immunol.</source>
                <year>2011</year>
                <volume>12</volume>
                <fpage>213</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">21278736</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.cale.2007.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cale</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldblatt</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology.</article-title>
                <source>Clin Exp Immunol.</source>
                <year>2007</year>
                <volume>148</volume>
                <fpage>79</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">17286762</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.chiriaco.2014.1472">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chiriaco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farinelli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capo</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zonari</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scaramuzza</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Matteo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sergi</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Migliavacca</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bombelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giorda</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kajaste-Rudnitski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trono</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finocchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naldini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gentner</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aiuti</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis.</article-title>
                <source>Mol Ther.</source>
                <year>2014</year>
                <volume>22</volume>
                <fpage>1472</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">24869932</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.cole.2013.8">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKendrick</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Titman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cant</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearce</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cale</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldblatt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant.</article-title>
                <source>J Clin Immunol.</source>
                <year>2013</year>
                <volume>33</volume>
                <fpage>8</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">23011479</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.de_ravin.2011.e136">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Ravin</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Challipalli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shea</surname>
                    <given-names>YR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marciano</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilligoss</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquesen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Decastro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wickes</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kammeyer</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sigler</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sullivan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zelazny</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease.</article-title>
                <source>Clin Infect Dis.</source>
                <year>2011</year>
                <volume>52</volume>
                <fpage>e136</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">21367720</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.de_ravin.2008.1097">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Ravin</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naumann</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowen</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friend</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilligoss</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquesen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balow</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barron</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <article-title>Chronic granulomatous disease as a risk factor for autoimmune disease.</article-title>
                <source>J Allergy Clin Immunol.</source>
                <year>2008</year>
                <volume>122</volume>
                <fpage>1097</fpage>
                <lpage>103</lpage>
                <pub-id pub-id-type="pmid">18823651</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.de_ravin.2014.2726">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Ravin</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wickes</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiederhold</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakasone</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alimchandani</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>OConell A, Notarangelo L, Kang E, Malech HL, Zelazny AM. Paravertebral mushroom: identification of a novel specius of Phellinus as a human pathogen in chronic granulomatous disease.</article-title>
                <source>J Clin Microbiol.</source>
                <year>2014</year>
                <volume>52</volume>
                <fpage>2726</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24829241</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.dorman.2002.390">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dorman</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guide</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conville</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Decarlo</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Witebsky</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Nocardia infection in chronic granulomatous disease.</article-title>
                <source>Clin Infect Dis.</source>
                <year>2002</year>
                <volume>35</volume>
                <fpage>390</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12145721</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.elloumi.2014.517">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elloumi</surname>
                    <given-names>HZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Diagnostic assays for chronic granulomatous disease and other neutrophil disorders.</article-title>
                <source>Methods Mol Biol.</source>
                <year>2014</year>
                <volume>1124</volume>
                <fpage>517</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">24504972</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF24">
              <mixed-citation publication-type="web">EBMT Working Group. European Bone Marrow Transplantation/European Society for Immunodeficiencies guidelines for haematopoietic stem cell transplantation for primary immunodeficiencies. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ebmt.org/Contents/About-EBMT/Who-We-Are/ScientificCouncil/Documents/EBMT_ESID%20GUIDELINES%20FOR%20INBORN%20ERRORS%20FINAL%202011.pdf">online</ext-link>. 2011. Accessed 6-19-17.</mixed-citation>
            </ref>
            <ref id="cgd.REF.fattahi.2011.792">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fattahi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Badalzadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sedighipour</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Movahedi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fazlollahi</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansouri</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khotaei</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bemanian</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Behmanesh</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamidieh</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bazargan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamishi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zandieh</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chavoshzadeh</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohammadzadeh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahdaviani</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabatabaei</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalantari</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tajik</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maddah</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pourpak</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moin</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease.</article-title>
                <source>J Clin Immunol.</source>
                <volume>31</volume>
                <fpage>792</fpage>
                <lpage>801</lpage>
                <pub-id pub-id-type="pmid">21789723</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.feld.2008.1917">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Feld</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleiner</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoofnagle</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahlawat</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilligoss</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heller</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.</article-title>
                <source>Gastroenterology.</source>
                <year>2008</year>
                <volume>134</volume>
                <fpage>1917</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">18439425</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.ferguson.2008.3264">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferguson</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lokuta</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Shanti</surname>
                    <given-names>HI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muhle</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bing</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huttenlocher</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype.</article-title>
                <source>Arthritis Rheum.</source>
                <year>2008</year>
                <volume>58</volume>
                <fpage>3264</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18821685</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.freeman.2009.32r">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.</article-title>
                <source>Pediatr Res.</source>
                <year>2009</year>
                <volume>65</volume>
                <fpage>32R</fpage>
                <lpage>37R</lpage>
                <pub-id pub-id-type="pmid">19190525</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.freeman.2011.806">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marciano</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uzel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Corticosteroids in the treatment of severe nocardia pneumonia in chronic granulomatous disease.</article-title>
                <source>Pediatr Infect Dis J.</source>
                <volume>30</volume>
                <fpage>806</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21412179</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.friend.2009.164">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Friend</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilligoss</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquesen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ulrick</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estwick</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowen</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Skin ulcers and disseminated abscesses are characteristic of Serratia marcescens infection in older patients with chronic granulomatous disease.</article-title>
                <source>J Allergy Clin Immunol.</source>
                <volume>124</volume>
                <fpage>164</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19477489</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.gallin.2003.2416">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alling</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wesley</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koziol</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marciano</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenstein</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Decarlo</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Starling</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Itraconazole to prevent fungal infections in chronic granulomatous disease.</article-title>
                <source>N Engl J Med.</source>
                <year>2003</year>
                <volume>348</volume>
                <fpage>2416</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">12802027</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.galluzzo.2008.745">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Galluzzo</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davila</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oleastro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zelazko</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenzweig</surname>
                    <given-names>SD</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Clinical and histopathological features and a unique spectrum of organisms significantly associated with chronic granulomatous disease osteomyelitis during childhood.</article-title>
                <source>Clin Infect Dis.</source>
                <volume>46</volume>
                <fpage>745</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18220479</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.garciaeulate.2006.482">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garcia-Eulate</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heller</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleiner</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choyke</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>CT and MRI of hepatic abscess in patients with chronic granulomatous disease.</article-title>
                <source>AJR Am J Roentgenol.</source>
                <volume>187</volume>
                <fpage>482</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">16861554</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.gentsch.2010.151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gentsch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaczmarczyk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Leeuwen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Boer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaus-Drobek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dagher</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaiser</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arkwright</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahr</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000f6;sen-Wolff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bochtler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Secord</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Britto-Williams</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saifi</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maddalena</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dbaibo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bustamante</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casanova</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roesler</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Alu-repeat-induced deletions within the NCF2 gene causing p67-phox-deficient chronic granulomatous disease (CGD).</article-title>
                <source>Hum Mutat.</source>
                <year>2010</year>
                <volume>31</volume>
                <fpage>151</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19953534</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.geramizadeh.2010.319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Geramizadeh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alborzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosseini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramzi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foroutan</surname>
                    <given-names>HR</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Primary splenic Hodgkin's disease in a patient with chronic granulomatous disease, a case report.</article-title>
                <source>Iran Red Crescent Med J.</source>
                <volume>12</volume>
                <fpage>319</fpage>
                <lpage>21</lpage>
              </element-citation>
            </ref>
            <ref id="cgd.REF.godoy.2008.1570">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Godoy</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vos</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooperberg</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lydell</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>NL</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Chest radiographic and CT manifestations of chronic granulomatous disease in adults.</article-title>
                <source>AJR Am J Roentgenol.</source>
                <volume>191</volume>
                <fpage>1570</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">18941103</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.gono.2008.1053">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gono</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yazaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agematsu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasui</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hidaka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizukami</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nunoi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubota</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Adult onset X-linked chronic granulomatous disease in a woman patient caused by a de novo mutation in paternal-origin CYBB gene and skewed inactivation of normal maternal X chromosome.</article-title>
                <source>Intern Med.</source>
                <year>2008</year>
                <volume>47</volume>
                <fpage>1053</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18520120</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.g_rlach.1997.1907">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>G&#x000f6;rlach</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roesler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkins</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chanock</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curnutte</surname>
                    <given-names>JT. A</given-names>
                  </name>
                </person-group>
                <article-title>p47-phox pseudogene carries the most common mutation causing p47-phox-deficient chronic granulomatous disease.</article-title>
                <source>J Clin Invest.</source>
                <year>1997</year>
                <volume>100</volume>
                <fpage>1907</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">9329953</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.greenberg.2006.e28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zelazny</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stock</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleiner</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenorio</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brinster</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorward</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease.</article-title>
                <source>PLoS Pathog.</source>
                <year>2006</year>
                <volume>2</volume>
                <fpage>e28</fpage>
                <pub-id pub-id-type="pmid">16617373</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.greenberg.2009.1577">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stock</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipuma</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <article-title>Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center.</article-title>
                <source>Clin Infect Dis.</source>
                <year>2009</year>
                <volume>48</volume>
                <fpage>1577</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19400745</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.greenberger.2002.685">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greenberger</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>Allergic bronchopulmonary aspergillosis.</article-title>
                <source>J Allergy Clin Immunol.</source>
                <year>2002</year>
                <volume>110</volume>
                <fpage>685</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">12417875</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.g_ng_r.2001.341">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>G&#x000fc;ng&#x000f6;r</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel-Bicik</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eich</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villi</surname>
                    <given-names>UV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hossle</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seger</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinert</surname>
                    <given-names>HC</given-names>
                  </name>
                </person-group>
                <article-title>Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease.</article-title>
                <source>Arch Dis Child.</source>
                <year>2001</year>
                <volume>85</volume>
                <fpage>341</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11567949</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.g_ng_r.2014.436">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>G&#x000fc;ng&#x000f6;r</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teira</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slatter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stussi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stepensky</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moshous</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermont</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Telles da Cunha</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlegel</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hough</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fasth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kentouche</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruhn</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandes</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachance</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bredius</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Resnick</surname>
                    <given-names>IB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belohradsky</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaspar</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schanz</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seger</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rentsch</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veys</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haddad</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albert</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassan</surname>
                    <given-names>M</given-names>
                  </name>
                  <collab>Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation</collab>
                </person-group>
                <article-title>Reduced-intensity conditionin and HLA-matched haematopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicenter study.</article-title>
                <source>Lancet.</source>
                <year>2014</year>
                <volume>383</volume>
                <fpage>436</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">24161820</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.hafner.1992.446">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hafner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enderlin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seger</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuthrich</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tudermann</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panizzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burg</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease.</article-title>
                <source>Br J Dermatol.</source>
                <year>1992</year>
                <volume>127</volume>
                <fpage>446</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">1419770</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.hasui.1999.589">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hasui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Japa</surname>
                    <given-names>SGPD</given-names>
                  </name>
                </person-group>
                <article-title>Chronic granulomatous disease in Japan: Incidence and natural history.</article-title>
                <source>Pediatrics International.</source>
                <year>1999</year>
                <volume>41</volume>
                <fpage>589</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">10530081</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.heim.2011.1154">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heim</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleisher</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stroncek</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leitman</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <article-title>The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.</article-title>
                <source>Transfusion.</source>
                <year>2011</year>
                <volume>51</volume>
                <fpage>1154</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">21175646</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.holland.2010.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Chronic granulomatous disease.</article-title>
                <source>Clin Rev Allergy Immunol.</source>
                <year>2010</year>
                <volume>38</volume>
                <fpage>3</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">19504359</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.hussain.2007.675">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hussain</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feld</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleiner</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoofnagle</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Eulate</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahlawat</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koziel</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilligoss</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choyke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heller</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Hepatic abnormalities in patients with chronic granulomatous disease.</article-title>
                <source>Hepatology.</source>
                <year>2007</year>
                <volume>45</volume>
                <fpage>675</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">17326162</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.ikincio_ullari.2005.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ikincio&#x0011f;ullari</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dogu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solaz</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reisli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kemahli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babacan</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis.</article-title>
                <source>Ther Apher Dial.</source>
                <year>2005</year>
                <volume>9</volume>
                <fpage>137</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">15828925</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.johnston.1985.50">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>RB</given-names>
                    <suffix>3rd</suffix>
                  </name>
                </person-group>
                <article-title>Recurrent severe infections in a girl with apparently variable expression of mosaicism for chronic granulomatous disease.</article-title>
                <source>J Pediatr.</source>
                <year>1985</year>
                <volume>106</volume>
                <fpage>50</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">3965681</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.jones.2008.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mcgrogan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flood</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thrasher</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldblatt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cant</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <article-title>Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry.</article-title>
                <source>Clin Exp Immunol.</source>
                <year>2008</year>
                <volume>152</volume>
                <fpage>211</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18410635</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.kang.2010.783">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theobald</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linton</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Long Priel</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhns</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <article-title>Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.</article-title>
                <source>Blood.</source>
                <year>2010</year>
                <volume>115</volume>
                <fpage>783</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">19965657</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.kang.2011.1319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marciano</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeRavin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zarember</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <article-title>Chronic granulomatous disease: Overview and hematopoietic stem cell transplantation.</article-title>
                <source>J Allergy Clin Immunol.</source>
                <year>2011</year>
                <volume>127</volume>
                <fpage>1319</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">21497887</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.kobayashi.2008.1389">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takanashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyatsuka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichinohe</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koike</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohagizawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deguchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higuchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakasugi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okabe</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tatsuzawa</surname>
                    <given-names>O.</given-names>
                  </name>
                </person-group>
                <article-title>Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan.</article-title>
                <source>Eur J Pediatr.</source>
                <year>2008</year>
                <volume>167</volume>
                <fpage>1389</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">18335239</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.k_ker.2013.1156">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000f6;ker</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camc&#x00131;o&#x0011f;lu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Leeuwen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x00131;l&#x00131;&#x000e7;</surname>
                    <given-names>S&#x0015e;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barlan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Y&#x00131;lmaz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Boer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avc&#x00131;lar</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pat&#x00131;ro&#x0011f;lu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Y&#x00131;ld&#x00131;ran</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye&#x0011f;in</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tezcan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanal</surname>
                    <given-names>&#x000d6;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients</article-title>
                <source>J Allergy Clin Immunol.</source>
                <year>2013</year>
                <volume>132</volume>
                <fpage>1156</fpage>
                <lpage>63.e5</lpage>
                <pub-id pub-id-type="pmid">23910690</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.kontras.1971.575">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kontras</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodenbender</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mcclave</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Interstitial cystitis in chronic granulomatous disease.</article-title>
                <source>J Urol.</source>
                <year>1971</year>
                <volume>105</volume>
                <fpage>575</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">5556710</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.kuhns.2010.2600">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kuhns</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvord</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heller</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feld</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pike</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marciano</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uzel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deravin</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priel</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soule</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zarember</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                </person-group>
                <article-title>Residual NADPH oxidase and survival in chronic granulomatous disease.</article-title>
                <source>N Engl J Med.</source>
                <year>2010</year>
                <volume>363</volume>
                <fpage>2600</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">21190454</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.laskey.2009.2368">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laskey</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gopal</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heller</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Twenty-year follow-up of esophageal involvement in chronic granulomatous disease.</article-title>
                <source>Am J Gastroenterol.</source>
                <year>2009</year>
                <volume>104</volume>
                <fpage>2368</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">19727106</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.lee.2008.224">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mak</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fok</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lau</surname>
                    <given-names>YL</given-names>
                  </name>
                </person-group>
                <article-title>Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease - A review of 17 patients living in a region endemic for tuberculosis.</article-title>
                <source>Pediatr Infect Dis J.</source>
                <year>2008</year>
                <volume>27</volume>
                <fpage>224</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">18277931</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.leiding.2012.694">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leiding</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marciano</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uzel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeRavin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilks</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkatesan</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerbe</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heller</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Corticosteroid therapy for liver abscess in chronic granulomatous disease.</article-title>
                <source>Clin Infect Dis.</source>
                <volume>54</volume>
                <fpage>694</fpage>
                <lpage>700</lpage>
                <pub-id pub-id-type="pmid">22157170</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.leusen.1996.1243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leusen</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Klein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilarius</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahlin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmblad</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diekmann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verhoeven</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease.</article-title>
                <source>J Exp Med.</source>
                <year>1996</year>
                <volume>184</volume>
                <fpage>1243</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">8879195</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.lewis.2008.372">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singla</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sergeant</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koty</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McPhail</surname>
                    <given-names>LC</given-names>
                  </name>
                </person-group>
                <article-title>X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation.</article-title>
                <source>Clin Immunol.</source>
                <year>2008</year>
                <volume>129</volume>
                <fpage>372</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">18774749</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.lugo_reyes.2011.543">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lugo Reyes</surname>
                    <given-names>SO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suarez</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herbigneaux</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pacquement</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000e9;guerre</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivi&#x000e8;re</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Suremain</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rose</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feinberg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malahoui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanche</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casanova</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bustamante</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Hodgkin lymphoma in 2 children with chronic granulomatous disease.</article-title>
                <source>J Allergy Clin Immunol.</source>
                <year>2011</year>
                <volume>127</volume>
                <fpage>543</fpage>
                <lpage>4.e1</lpage>
                <pub-id pub-id-type="pmid">21168906</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.mailman.2005.245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mailman</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <article-title>Francisella philomiragia adenitis and pulmonary nodules in a child with chronic granulomatous disease.</article-title>
                <source>Can J Infect Dis Med Microbiol.</source>
                <year>2005</year>
                <volume>16</volume>
                <fpage>245</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18159552</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.marciano.2004.462">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marciano</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenzweig</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleiner</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darnell</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anaya-O'Brien</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilligoss</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Gastrointestinal involvement in chronic granulomatous disease.</article-title>
                <source>Pediatrics.</source>
                <year>2004</year>
                <volume>114</volume>
                <fpage>462</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15286231</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.marciano.2015.1176">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marciano</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spalding</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzgerald</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osgood</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yockey</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darnell</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daub</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boris</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rump</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haney</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhns</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenzweig</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zelazny</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mason</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeRavin</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olivier</surname>
                    <given-names>KN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uzel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heller</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerbe</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Common severe infections in chronic granulomatous disease.</article-title>
                <source>Clin Infect Dis.</source>
                <year>2015</year>
                <volume>60</volume>
                <fpage>1176</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">25537876</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.martire.2008.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martire</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rondelli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soresina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pignata</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broccoletti</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finocchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gattorno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabusin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azzari</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dellepiane</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrogrande</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trizzino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Bartolomeo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpino</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locatelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maccario</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierani</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Putti</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stabile</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Notarangelo</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugazio</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plebani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Mattia</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study.</article-title>
                <source>Clin Immunol.</source>
                <year>2008</year>
                <volume>126</volume>
                <fpage>155</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">18037347</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.matute.2009.3309">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matute</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arias</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wrobel</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waterhouse</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>XJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchal</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stull</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steele</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kellner</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meroueh</surname>
                    <given-names>SO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nauseef</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinauer</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.</article-title>
                <source>Blood.</source>
                <year>2009</year>
                <volume>114</volume>
                <fpage>3309</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">19692703</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.mauch.2007.890">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mauch</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lun</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Gorman</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zychlinsky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuchs</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oelschlagel</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutter</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen-Wolff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roesler</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD.</article-title>
                <source>Clin Chem.</source>
                <year>2007</year>
                <volume>53</volume>
                <fpage>890</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17384005</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.morgenstern.1997.207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morgenstern</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gifford</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doerschuk</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinauer</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus.</article-title>
                <source>J Exp Med.</source>
                <year>1997</year>
                <volume>185</volume>
                <fpage>207</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">9016870</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.newburger.1979.178">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Newburger</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rothchild</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hobbins</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malawista</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahoney</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal diagnosis of chronic granulomatous disease.</article-title>
                <source>N Engl J Med.</source>
                <year>1979</year>
                <volume>300</volume>
                <fpage>178</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">83536</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.ott.2006.401">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ott</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarzwaelder</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siler</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koehl</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glimm</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhlcke</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schilz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunkel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naundorf</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brinkmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deichmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ball</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunbar</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Du</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copeland</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luthi</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thrasher</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoelzer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Von Kalle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seger</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grez</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.</article-title>
                <source>Nat Med.</source>
                <year>2006</year>
                <volume>12</volume>
                <fpage>401</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16582916</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.ozsahin.1998.2719">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ozsahin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Planta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinert</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lauener</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuchschmid</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willi</surname>
                    <given-names>UV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozsahin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crompton</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seger</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <article-title>Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.</article-title>
                <source>Blood.</source>
                <year>1998</year>
                <volume>92</volume>
                <fpage>2719</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">9763555</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.parekh.2011.460">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parekh</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofstra</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Church</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coates</surname>
                    <given-names>TD</given-names>
                  </name>
                </person-group>
                <article-title>Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease.</article-title>
                <source>Pediatr Blood Cancer.</source>
                <year>2011</year>
                <volume>56</volume>
                <fpage>460</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">21225928</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.peng.2007.142">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redman</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westhoff</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Insights into extensive deletions around the XK locus associated with McLeod phenotype and characterization of two novel cases.</article-title>
                <source>Gene.</source>
                <year>2007</year>
                <volume>392</volume>
                <fpage>142</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">17300882</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.ramesh.2014.130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ramesh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Resnick</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hui</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maglione</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kattan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouvier</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LaBombardi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Victor</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaturvedi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunningham-Rundles</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Phellinus tropicalis abscesses in a patient with chronic granulomatous disease.</article-title>
                <source>J Clin Immunol.</source>
                <year>2014</year>
                <volume>34</volume>
                <fpage>130</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">24310980</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.raptaki.2013.1302">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raptaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varela</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spanou</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tzanoudaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tantou</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liatsis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Constantinidou</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakoula</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanariou</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Chronic Granulomatous Disease: A 25-year Patient Registry Based on a Multistep Diagnostic Procedure, from the Referral Center for Primary Immunodeficiencies in Greece.</article-title>
                <source>J Clin Immunol.</source>
                <year>2013</year>
                <volume>33</volume>
                <fpage>1302</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24081483</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.reichenbach.2008.e778">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reichenbach</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van de Velde</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Rycke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staessen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Platteau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baetens</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000fc;ng&#x000f6;r</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozsahin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siler</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seger</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liebaers</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching.</article-title>
                <source>Pediatrics.</source>
                <year>2008</year>
                <volume>122</volume>
                <fpage>e778</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">18762514</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.ristoff.2001.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ristoff</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayatepek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsson</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Long-term clinical outcome in patients with glutathione synthetase deficiency.</article-title>
                <source>J Pediatr.</source>
                <year>2001</year>
                <volume>139</volume>
                <fpage>79</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">11445798</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.roesler.2005.513">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roesler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porksen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Von Bernuth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahr</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen-Wolff</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Benefit assessment of preventive medical check-ups in patients suffering from chronic granulomatous disease (CGD).</article-title>
                <source>J Eval Clin Pract.</source>
                <year>2005</year>
                <volume>11</volume>
                <fpage>513</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">16364103</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.roos.1996.1663">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Boer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuribayashi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meischl</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weening</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segal</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x000c5;hlin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemet</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hossle</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernatowska-Matuszkiewicz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Middleton-Price</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease.</article-title>
                <source>Blood.</source>
                <year>1996</year>
                <volume>87</volume>
                <fpage>1663</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">8634410</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.roos.2010a.291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhns</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maddalena</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bustamante</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kannengiesser</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Boer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Leeuwen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000f6;ker</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolach</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roesler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stasia</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update).</article-title>
                <source>Blood Cells Mol Dis.</source>
                <year>2010a</year>
                <volume>44</volume>
                <fpage>291</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20167518</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.roos.2010b.246">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhns</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maddalena</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roesler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ariga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avcin</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Boer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bustamante</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Condino-Neto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Matteo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kannengiesser</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000f6;ker</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondratenko</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Leeuwen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marodi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nunoi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stasia</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ventura</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Witwer</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolach</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                </person-group>
                <article-title>Hematologically important mutations: X-linked chronic granulomatous disease (third update).</article-title>
                <source>Blood Cells Mol Dis.</source>
                <year>2010b</year>
                <volume>45</volume>
                <fpage>246</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">20729109</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.segal.2005.1684">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Segal</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnhart</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.</article-title>
                <source>Clin Infect Dis.</source>
                <year>2005</year>
                <volume>40</volume>
                <fpage>1684</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15889369</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.segal.1998.345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Segal</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeCarlo</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Aspergillus nidulans infection in chronic granulomatous disease.</article-title>
                <source>Medicine</source>
                <year>1998</year>
                <volume>77</volume>
                <fpage>345</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">9772923</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.shigemura.2015.371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shigemura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakazawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amano</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sudo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobabyashi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koike</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agematsu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Subcutaneous abscess due to basidiomycete Phellinus mori in a patient with chronic granulomatous disease.</article-title>
                <source>Infection.</source>
                <year>2015</year>
                <volume>43</volume>
                <fpage>371</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">25600930</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.siddiqui.2007.673">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Siddiqui</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilligoss</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuijpers</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masur</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Witebsky</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shea</surname>
                    <given-names>YR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease.</article-title>
                <source>Clin Infect Dis.</source>
                <year>2007</year>
                <volume>45</volume>
                <fpage>673</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">17712749</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.sirinavin.2005.559">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sirinavin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Techasaensiri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benjaponpitak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pornkul</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vorachit</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Invasive Chromobacterium violaceum infection in children: case report and review.</article-title>
                <source>Pediatr Infect Dis J.</source>
                <year>2005</year>
                <volume>24</volume>
                <fpage>559</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">15933571</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.stein.2010.198">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ott</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schultze-Strasser</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jauch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burwinkel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwable</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glimm</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koehl</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preiss</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ball</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gohring</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarzwaelder</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karakaya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tchatchou</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reinecke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhlcke</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlegelberger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thrasher</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoelzer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seger</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Von Kalle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grez</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.</article-title>
                <source>Nat Med.</source>
                <year>2010</year>
                <volume>16</volume>
                <fpage>198</fpage>
                <lpage>204</lpage>
                <pub-id pub-id-type="pmid">20098431</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.teimourian.2010.587">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Teimourian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Boer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Molecular basis of autosomal recessive chronic granulomatous disease in Iran.</article-title>
                <source>J Clin Immunol.</source>
                <year>2010</year>
                <volume>30</volume>
                <fpage>587</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">20407811</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.towbin.2010.657">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Towbin</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaves</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Chronic granulomatous disease.</article-title>
                <source>Pediatr Radiol.</source>
                <volume>40</volume>
                <fpage>657</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">20135113</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.uzel.2010.1429">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uzel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orange</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poliak</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marciano</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heller</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Complications of tumor necrosis factor-alpha blockade in chronic granulomatous disease-related colitis.</article-title>
                <source>Clin Infect Dis.</source>
                <year>2010</year>
                <volume>51</volume>
                <fpage>1429</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">21058909</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.van_den_berg.2009.e5234">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van den Berg</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Koppen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahlin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belohradsky</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernatowska</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corbeel</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espa&#x000f1;ol</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurenko-Deptuch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mouy</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petropoulou</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roesler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seger</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stasia</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valerius</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weening</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolach</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuijpers</surname>
                    <given-names>TW</given-names>
                  </name>
                </person-group>
                <article-title>Chronic granulomatous disease: the European experience.</article-title>
                <source>PLoS One.</source>
                <year>2009</year>
                <volume>4</volume>
                <fpage>e5234</fpage>
                <pub-id pub-id-type="pmid">19381301</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.vinh.2009.1411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vinh</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shea</surname>
                    <given-names>YR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinberg</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Mucormycosis in chronic granulomatous disease: association with iatrogenic immunosuppression.</article-title>
                <source>J Allergy Clin Immunol.</source>
                <volume>123</volume>
                <fpage>1411</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">19368967</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.von_planta.1997.234">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>von Planta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozsahin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroten</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stauffer</surname>
                    <given-names>UG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seger</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <article-title>Greater omentum flaps and granulocyte transfusions as combined therapy of liver abscess in chronic granulomatous disease.</article-title>
                <source>Eur J Pediatr Surg.</source>
                <year>1997</year>
                <volume>7</volume>
                <fpage>234</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9297520</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.vowells.1996.104">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vowells</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleisher</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sekhsaria</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alling</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maguire</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <article-title>Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease.</article-title>
                <source>J Pediatr.</source>
                <year>1996</year>
                <volume>128</volume>
                <fpage>104</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8551399</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.wang.2013.917">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marciano</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <article-title>Molecular identification of bacterial DNA in the chorioretinal scars od chronic granulomatous disease.</article-title>
                <source>J Clin Immunol.</source>
                <year>2013</year>
                <volume>33</volume>
                <fpage>917</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">23636897</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.walther.1992.1314">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walther</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choyke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venzon</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                </person-group>
                <article-title>The urological manifestations of chronic granulomatous disease.</article-title>
                <source>J Urol.</source>
                <year>1992</year>
                <volume>147</volume>
                <fpage>1314</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1569675</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.whitin.1988.289">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Whitin</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <article-title>Disorders of respiratory burst termination.</article-title>
                <source>Hematol Oncol Clin North Am.</source>
                <year>1988</year>
                <volume>2</volume>
                <fpage>289</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">2839461</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.winkelstein.2000.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Winkelstein</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marino</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curnutte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ochs</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quie</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buckley</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foster</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chanock</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickler</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Chronic granulomatous disease. Report on a national registry of 368 patients.</article-title>
                <source>Medicine (Baltimore)</source>
                <year>2000</year>
                <volume>79</volume>
                <fpage>155</fpage>
                <lpage>69</lpage>
                <pub-id pub-id-type="pmid">10844935</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.wolach.2005.61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolach</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scharf</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gavrieli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Boer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a novel mutation in CYBB.</article-title>
                <source>Blood.</source>
                <year>2005</year>
                <volume>105</volume>
                <fpage>61</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15308575</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.wolach.2008.103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolach</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gavrieli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Boer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gottesman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Ari</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rottem</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlesinger</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grisaru-Soen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Etzioni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients.</article-title>
                <source>Clin Immunol.</source>
                <year>2008</year>
                <volume>129</volume>
                <fpage>103</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">18708296</pub-id>
              </element-citation>
            </ref>
            <ref id="cgd.REF.yamazakinakashimada.2006.257">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamazaki-Nakashimada</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stiehm</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietropaolo-Cienfuegos</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez-Bautista</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espinosa-Rosales</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature.</article-title>
                <source>Ann Allergy Asthma Immunol.</source>
                <year>2006</year>
                <volume>97</volume>
                <fpage>257</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">16937761</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cgd.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cgd.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>11 February 2016 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>9 August 2012 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>7 November 2011 (jl) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
